rfhg_76162.1

Basic information about the TSS

---

TSS ID: rfhg_76162.1 Species: human Chr: chr5		Start: 176536631 End: 176536656 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3797699,EH38E2434872)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000509404.1:301 GeneID: 22838 HGNC/MGI_ID: HGNC:19180 UniProt_ID: Nearer transcript ids and distances:

Gene_name: ring finger protein 44 Gene_symbol: RNF44 Gene_synonyms: KIAA1100 Gene_source: HGNC:19180

TATA-Box annotation

---

Distance to TSS:	759
Nearest PromoterID:	NM_014901
Entrez ID:	22838
Nearest Unigene:	Hs.434888
Nearest Refseq:	NM_014901
Nearest Ensembl:	ENSG00000146083
Gene Name:	ring finger protein 44
Gene Alias:	-
Gene Type:	protein-coding
CpG%:	0.120000
GC%:	0.692308
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RNF44 p2@RNF44 p3@RNF44 p4@RNF44 p5@RNF44 p6@RNF44 p7@RNF44 p8@RNF44 p9@RNF44 p10@RNF44
Sample		p1@RNF44	p2@RNF44	p3@RNF44	p4@RNF44	p5@RNF44	p6@RNF44	p7@RNF44	p8@RNF44	p9@RNF44	p10@RNF44
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	2.34	2.53	2.53	1.17	1.56	1.95	2.73	3.51	0.78	0.97
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	1.82	1.82	5.26	1.21	0.61	3.84	3.84	2.23	1.01	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	0.77	2.89	4.63	2.12	1.35	4.63	2.70	1.93	1.16	1.35
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	2.70	2.91	6.03	0.83	1.46	4.16	3.33	2.29	1.46	1.87
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	2.47	2.25	6.30	2.02	1.57	4.50	2.70	4.50	1.80	3.37
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	3.68	2.71	5.23	1.16	2.33	3.68	4.85	2.52	1.16	2.52
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	2.40	2.61	4.58	1.31	3.05	3.92	3.27	2.40	2.83	1.53
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	1.94	2.42	4.84	1.45	1.70	4.60	2.66	2.42	1.45	1.70
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	2.14	4.06	3.85	1.07	2.56	3.42	3.63	1.50	1.50	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	2.90	8.11	3.48	0.00	9.27	0.58	2.32	4.06	5.22	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	4.85	4.04	2.83	2.43	4.04	2.02	2.02	2.43	2.02	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	2.03	1.63	3.66	1.63	4.47	2.85	2.03	1.22	2.85	2.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	3.87	4.51	3.55	1.93	0.64	0.97	1.45	1.29	1.93	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	3.61	3.31	4.36	1.35	0.75	1.65	0.60	0.75	3.01	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	3.51	3.73	2.85	1.76	1.10	0.66	1.54	0.44	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	4.02	2.77	4.53	1.26	1.01	0.75	0.50	0.75	1.01	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	1.75	3.71	1.53	1.31	0.22	0.87	1.31	0.87	0.87	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	4.22	2.11	1.27	1.27	0.42	2.11	1.69	0.84	2.95	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	2.67	3.20	2.67	0.53	0.53	0.53	0.00	1.07	1.60	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	3.31	3.91	3.61	1.35	1.20	0.75	1.20	0.45	1.35	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	2.81	3.34	3.61	1.34	1.20	1.07	1.60	0.67	1.87	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	2.93	4.49	3.63	1.21	0.69	0.86	1.21	2.42	1.90	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	4.39	4.27	4.27	1.42	0.78	1.29	0.52	1.55	2.33	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	2.18	2.18	4.13	0.73	0.49	0.73	0.49	0.49	0.49	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	1.29	4.39	3.10	2.06	1.81	1.03	1.55	1.29	1.81	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	2.22	3.48	3.48	0.63	1.27	0.95	0.95	1.58	1.90	1.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	2.20	2.20	3.30	0.55	0.00	1.10	0.55	3.30	2.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	4.01	1.89	3.54	2.59	1.41	0.71	2.36	1.18	1.41	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	2.26	2.26	3.39	0.97	0.48	0.65	1.94	0.48	1.13	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	2.71	4.16	3.08	1.09	0.72	2.35	1.09	0.90	1.27	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	2.09	2.09	2.30	1.47	0.42	0.63	1.26	0.84	0.42	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	2.74	1.95	2.93	0.78	0.59	0.78	0.20	1.37	1.56	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	1.48	2.32	4.01	0.63	0.84	1.69	1.48	0.84	1.69	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	2.97	1.48	2.31	0.00	0.66	0.33	0.66	1.81	2.64	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	2.43	1.50	2.24	0.37	0.75	0.75	1.50	0.56	0.37	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	1.72	1.72	1.72	0.57	0.57	1.15	1.15	0.77	2.11	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	0.61	1.23	0.82	0.20	0.20	0.41	0.61	0.61	0.20	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	2.01	1.81	1.41	0.40	0.20	0.81	1.61	0.60	0.40	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	2.43	1.62	0.54	0.27	0.00	0.27	1.08	0.00	0.27	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	0.96	0.96	1.92	0.48	0.24	0.24	0.24	0.48	0.48	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	1.65	1.88	0.47	0.24	0.24	0.71	0.24	0.24	0.47	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	1.76	0.73	1.90	0.59	0.44	0.59	0.59	0.44	0.44	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	1.69	2.74	2.32	0.42	0.21	0.84	0.21	0.84	1.48	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	1.40	1.75	1.92	0.87	0.00	0.17	0.70	0.87	1.22	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	1.41	1.61	1.61	0.20	0.60	0.80	0.80	0.20	0.80	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	1.63	2.56	2.09	1.40	0.47	0.70	1.16	0.93	0.93	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	2.64	2.88	2.64	0.96	0.24	0.48	0.48	0.24	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	0.30	2.68	3.58	0.89	0.00	0.60	0.60	0.89	0.60	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	1.44	4.07	2.63	0.96	1.20	1.20	0.72	0.48	0.96	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	1.62	3.24	2.83	0.20	0.40	1.01	0.81	1.42	2.22	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	3.28	3.48	2.87	0.61	0.82	0.61	1.02	1.02	0.61	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	2.00	1.11	4.23	0.89	0.44	1.11	0.89	0.44	1.33	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	13.99	0.00	13.99	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	2.84	1.06	3.55	1.06	0.71	1.42	0.35	1.42	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	3.31	3.65	1.33	0.66	0.99	0.99	0.33	0.66	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	3.36	4.19	3.36	0.84	0.84	2.52	3.36	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	2.30	2.30	3.67	0.46	0.46	1.84	1.84	0.00	0.92	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	3.57	2.92	1.94	0.65	0.32	1.62	0.65	1.30	1.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	1.93	2.25	3.21	1.61	0.64	0.96	0.00	0.96	1.28	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	2.51	3.14	4.09	0.63	0.31	1.26	0.63	0.94	0.63	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	3.53	1.41	5.64	0.71	0.00	0.71	0.00	2.82	2.12	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	1.68	1.68	2.24	1.12	0.00	1.12	0.00	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	7.96	0.80	1.59	1.59	1.59	3.18	1.59	1.59	3.98	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	4.08	0.68	3.40	1.70	1.70	1.36	1.36	1.02	1.02	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	6.50	3.25	3.57	0.97	0.32	1.62	0.32	0.00	1.30	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	4.26	1.42	1.77	1.06	0.00	0.71	0.71	0.35	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	16.16	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	23.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	3.90	3.90	1.46	0.49	0.49	0.49	0.49	0.00	0.49	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	3.47	1.49	0.99	0.99	0.00	0.00	0.00	0.00	0.50	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	2.35	0.47	0.94	0.47	0.00	1.41	0.47	0.00	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	3.31	1.99	1.66	0.33	0.99	0.00	0.33	0.66	0.99	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	3.71	1.24	2.47	0.31	0.31	0.62	0.00	0.62	0.31	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	2.45	2.45	0.61	0.00	0.92	0.31	0.31	0.61	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	2.38	1.27	0.48	0.00	0.16	0.16	0.16	0.48	0.48	0.00
Adipocyte - breast, donor2	11327-117E4	3.69	1.60	0.64	0.00	0.16	0.16	0.00	0.00	0.48	0.32
Adipocyte - omental, donor1	11473-119C6	3.05	2.16	0.89	0.00	0.64	0.25	0.00	0.64	0.13	0.00
Adipocyte - omental, donor2	11474-119C7	0.00	1.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	3.01	2.68	0.33	0.00	0.00	0.67	0.00	0.00	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	0.00	0.64	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	0.00	1.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	0.00	1.81	0.90	0.00	0.00	0.00	0.45	0.90	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	0.70	1.56	0.17	0.17	0.17	0.35	0.00	0.00	0.17	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	4.50	4.11	2.35	1.17	0.78	0.39	0.59	1.37	1.76	1.76
Adipocyte differentiation, day04, donor2	13022-139D7	4.63	4.89	1.54	0.77	1.29	0.26	0.77	1.54	1.80	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	3.90	3.07	1.12	0.84	1.95	1.39	0.84	0.56	1.12	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	3.53	3.53	0.59	0.59	1.76	0.00	2.35	0.59	1.76	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	4.10	5.39	2.65	0.64	1.21	0.72	1.45	0.72	0.80	1.69
Adipocyte differentiation, day08, donor2	13023-139D8	3.23	6.13	2.58	0.32	1.29	0.00	0.00	0.65	0.32	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	2.67	3.73	1.07	0.00	1.60	1.07	2.67	0.00	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	4.45	2.23	1.11	0.00	0.56	0.00	0.00	1.11	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	2.08	4.16	0.83	0.00	1.25	0.00	0.00	0.00	0.42	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	1.51	3.52	0.50	0.25	0.50	0.50	0.50	0.25	0.25	1.76
Adipocyte differentiation, day12, donor3	13027-139E3	2.95	1.64	0.33	0.65	0.98	0.33	0.00	0.65	1.31	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	2.74	1.83	1.22	0.61	0.61	0.00	0.00	0.00	0.00	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	9.06	5.97	3.09	0.44	1.55	1.10	2.21	2.21	1.99	1.77
Alveolar Epithelial Cells, donor2	11590-120G6	7.89	4.66	3.23	1.79	1.08	1.08	3.59	1.43	0.36	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	9.58	3.59	2.40	0.00	2.40	1.20	0.00	5.99	1.20	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	5.04	1.62	0.90	0.72	0.36	0.54	1.44	0.90	0.72	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	6.69	1.67	0.00	0.00	0.00	5.02	0.00	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	9.86	2.88	2.05	0.41	0.82	0.21	1.64	0.62	0.00	0.82
Anulus Pulposus Cell, donor1	11248-116E6	2.29	1.37	0.80	0.23	0.11	0.69	0.69	0.46	0.69	0.57
Anulus Pulposus Cell, donor2	11463-119B5	2.20	1.47	1.22	0.00	0.24	0.00	0.49	0.00	0.24	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	0.45	1.80	0.90	0.00	0.45	0.45	0.45	0.45	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	2.60	2.17	1.30	0.87	0.00	0.00	0.00	0.87	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	2.14	0.00	0.00	2.14	0.00	0.00	0.00	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	4.18	0.00	0.60	0.30	0.60	0.30	0.00	0.30	0.00	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	1.26	0.00	1.26	0.00	1.26	0.00	0.00	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	1.32	1.32	0.66	0.00	0.00	0.00	1.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	2.60	0.97	0.97	0.97	0.00	0.97	0.32	0.32	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	2.43	1.94	0.49	0.00	0.00	0.00	0.49	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	1.78	0.59	0.59	0.00	0.00	0.00	0.00	0.59	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	2.26	0.38	1.13	0.00	0.75	0.00	0.75	0.38	0.75	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	7.98	0.73	0.73	0.00	0.73	0.00	0.00	0.00	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	2.51	0.00	0.00	0.00	0.00	1.25	0.00	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	2.64	0.66	0.66	0.00	0.33	0.33	0.33	0.33	0.49	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	2.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.36	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	0.90	0.30	0.30	0.45	0.15	0.15	0.15	0.00	0.30	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	1.61	0.54	1.07	0.54	0.00	0.00	1.07	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	2.65	0.38	0.76	0.19	0.19	0.38	0.38	0.19	0.00	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	4.01	1.34	1.07	0.00	0.27	0.27	0.27	0.00	0.27	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	0.00	0.98	3.90	0.00	0.00	0.98	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	3.65	0.83	1.00	0.17	0.33	0.83	0.66	0.17	0.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	1.20	1.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	3.77	0.69	1.37	0.17	0.34	0.17	0.17	0.17	0.17	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	0.00	0.00	0.00	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	4.85	0.49	0.00	0.00	0.97	1.46	0.49	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	1.14	1.14	1.14	0.38	0.76	0.38	0.00	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	2.42	0.00	0.00	0.00	1.21	0.00	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	3.42	0.57	0.00	0.00	0.00	1.14	0.57	0.57	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	1.92	1.28	0.43	0.21	0.64	0.86	0.43	0.21	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	2.32	0.52	0.26	0.00	0.00	0.26	0.26	0.77	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	2.82	0.47	1.41	0.94	0.47	0.00	1.41	0.00	0.00	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	3.54	0.64	0.32	0.32	0.32	0.32	0.00	0.00	0.64	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	1.43	0.00	0.00	0.00	0.00	1.43	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	3.51	2.34	1.75	0.00	0.58	0.00	0.00	0.00	0.58	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	2.41	2.11	0.00	0.90	0.30	0.00	0.00	0.30	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	3.56	1.19	1.19	0.00	0.00	2.38	0.00	2.38	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	4.07	0.51	1.02	0.51	0.51	0.00	0.51	0.51	1.02	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	2.55	0.76	0.51	0.25	0.76	0.25	0.76	0.25	0.76	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	1.27	0.64	0.00	0.00	0.64	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	1.29	0.43	0.86	0.86	0.00	0.00	0.00	0.43	0.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	2.75	0.85	0.85	0.21	0.00	0.42	0.21	0.42	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	2.03	0.58	1.16	0.29	0.29	0.87	0.00	0.29	0.58	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	2.83	1.89	0.94	0.94	1.89	0.00	0.00	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	2.71	0.85	0.68	0.17	0.34	0.68	0.17	0.17	0.51	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	0.00	0.00	0.00	0.00	0.00	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	8.45	0.00	0.00	0.00	2.11	0.00	0.00	0.00	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	3.00	0.43	0.86	0.00	0.21	0.21	0.64	0.21	0.86	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	2.41	0.00	0.60	0.60	0.00	0.00	0.60	0.60	0.00	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	1.46	0.73	0.00	0.00	0.00	0.00	0.73	0.73	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	1.38	0.46	0.23	0.23	0.69	0.23	0.00	0.00	0.69	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	2.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	1.02	0.76	0.51	0.25	0.00	0.25	0.00	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	3.10	0.83	1.03	0.21	0.83	0.83	0.62	0.21	0.41	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	2.14	0.61	1.53	0.31	0.31	0.00	0.31	0.00	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	3.82	1.91	0.96	0.48	0.00	0.48	0.96	0.00	0.00	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	2.66	1.11	0.44	0.00	0.44	0.22	0.44	0.00	0.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	1.53	0.00	1.53	0.00	1.53	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	3.32	1.11	0.55	0.00	0.00	0.55	0.55	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	3.71	2.12	0.53	0.00	0.53	0.00	0.79	0.26	1.06	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	1.82	0.73	0.36	0.00	0.36	0.00	0.00	0.36	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	4.91	1.47	2.33	0.86	0.98	0.49	0.74	1.35	0.61	0.37
Astrocyte - cerebellum, donor2	11580-120F5	4.11	1.03	0.86	0.51	0.86	0.34	1.20	0.34	0.51	0.51
Astrocyte - cerebellum, donor3	11661-122F5	5.45	1.26	2.31	0.42	0.84	1.26	2.31	0.84	1.47	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	4.18	1.74	2.79	0.70	1.05	1.39	1.05	1.74	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	3.72	2.43	2.26	1.29	0.65	1.29	1.94	0.32	0.49	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	3.28	2.68	2.54	0.89	1.49	1.79	2.24	0.89	0.75	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	5.39	19.96	12.50	7.57	2.75	2.87	2.64	1.38	7.45	2.41
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	4.26	18.29	14.78	7.52	1.88	3.26	2.63	1.88	6.77	3.51
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	4.21	15.93	11.72	8.31	1.93	2.05	2.39	1.59	7.28	1.82
Basophils, donor1	12241-129G9	30.86	13.08	4.97	4.18	4.18	2.35	0.26	0.78	1.57	1.31
Basophils, donor2	12242-129H1	43.66	5.41	8.66	9.74	6.49	6.49	0.00	4.33	0.72	0.72
Basophils, donor3	12243-129H2	29.99	12.49	7.20	5.29	3.53	2.06	1.91	1.18	1.91	0.88
Bronchial Epithelial Cell, donor1	11511-119G8	6.47	4.31	1.51	0.22	1.51	1.29	3.67	1.08	0.65	1.29
Bronchial Epithelial Cell, donor2	11591-120G7	13.26	5.49	1.37	1.37	2.29	1.83	2.29	2.29	0.46	1.83
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00	0.00	0.00	0.00	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	5.65	1.88	1.26	1.26	0.00	0.63	0.00	1.88	1.88	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	8.11	4.78	2.70	2.29	1.66	1.04	1.46	1.46	1.87	1.87
Bronchial Epithelial Cell, donor6	11461-119B3	4.38	1.15	0.69	0.46	0.46	0.46	0.46	0.46	0.23	1.15
Bronchial Epithelial Cell, donor7	11769-123I5	5.94	3.78	1.26	0.18	2.16	0.72	1.08	1.08	1.08	1.08
Burkitt's lymphoma cell line:DAUDI	10422-106C8	2.47	2.78	6.18	7.73	3.81	1.55	1.03	3.19	2.68	2.06
Burkitt's lymphoma cell line:RAJI	10476-106I8	6.06	5.59	10.25	5.36	3.96	3.26	2.79	2.56	3.73	3.26
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	12.15	3.20	9.27	15.99	1.60	2.88	3.20	1.28	2.88	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	0.00	10.34	0.00	0.00	0.00	0.00	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	29.30	13.53	6.76	7.89	5.64	1.13	0.00	0.56	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	34.34	20.42	9.28	10.21	5.57	3.34	0.56	2.04	1.86	0.93
CD14+ Monocytes, donor3	11381-118B4	27.88	15.37	9.22	8.78	4.83	1.54	0.88	2.20	1.32	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	6.51	18.96	5.38	2.26	1.13	0.85	0.57	0.28	0.28	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	10.99	17.44	4.17	3.41	1.90	1.90	0.38	0.38	0.76	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	9.20	24.98	3.94	1.64	2.63	0.66	0.00	0.99	0.66	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	19.95	15.32	3.04	1.45	1.45	1.45	0.43	1.30	0.87	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	11.47	9.05	3.92	0.30	2.72	0.30	0.30	0.00	0.00	1.21
CD14+ monocytes - mock treated, donor3	11883-125D2	12.79	18.95	3.55	2.13	1.90	0.95	0.24	0.95	1.66	1.18
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	11.05	3.18	2.01	1.51	1.84	0.67	0.67	0.17	0.33	1.34
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	11.04	1.38	1.38	0.28	3.31	0.00	0.28	0.28	0.55	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	12.15	2.48	0.74	0.99	2.48	0.74	0.00	0.25	0.25	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	24.67	4.50	2.15	0.98	2.94	0.00	0.00	0.20	0.00	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	22.26	2.14	1.96	1.42	2.67	0.00	0.00	0.00	0.00	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	19.59	1.96	1.31	1.09	2.61	1.09	0.22	0.00	0.44	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	22.71	4.92	3.98	0.94	4.21	0.23	0.47	0.70	0.00	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	17.95	5.81	1.58	1.58	5.28	0.53	1.58	0.00	0.53	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	25.52	5.55	3.33	0.00	6.66	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	15.02	7.29	1.04	0.30	1.64	0.59	0.00	0.00	0.15	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	5.39	3.39	0.80	0.60	1.60	0.40	0.20	0.20	0.00	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	6.87	2.08	0.42	0.21	1.25	0.42	0.21	0.00	0.00	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	11.90	2.75	1.37	1.37	2.75	0.46	0.23	0.23	0.00	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	11.54	1.36	2.04	0.45	1.81	0.90	0.00	0.45	0.00	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	9.60	1.75	1.75	1.31	1.75	0.87	0.87	0.44	0.00	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	29.59	6.19	2.69	0.54	4.30	0.27	0.00	0.54	0.00	1.61
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	27.74	3.49	1.92	0.52	4.01	1.40	0.52	0.35	0.17	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	31.14	3.37	1.68	0.84	4.63	0.42	0.00	0.00	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	10.47	1.47	0.73	0.55	2.76	0.37	0.37	0.00	0.00	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	6.69	2.11	0.70	0.70	2.82	0.35	0.00	0.35	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	8.34	1.32	1.75	0.00	0.44	0.44	0.00	0.44	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	27.90	3.84	2.44	1.22	4.18	0.52	0.52	0.17	0.17	0.87
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	22.67	2.97	2.23	1.86	4.09	0.37	0.00	0.00	0.00	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	22.63	0.86	1.29	0.00	3.45	0.86	0.43	0.43	0.00	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	11.88	2.46	0.82	1.23	0.82	0.00	0.00	0.00	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	9.27	1.85	0.70	0.46	3.25	0.46	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	8.58	0.93	0.70	0.46	2.09	0.70	0.00	0.23	0.00	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	11.33	12.64	4.14	3.71	1.09	1.09	0.87	0.44	1.53	0.87
CD14+CD16+ Monocytes, donor2	11801-124D1	16.63	14.55	6.47	6.01	1.39	1.85	1.85	1.85	3.00	1.39
CD14+CD16+ Monocytes, donor3	11912-125G4	8.66	10.18	2.60	2.60	1.30	1.08	0.00	1.08	1.30	1.08
CD14+CD16- Monocytes, donor1	11788-124B6	27.41	26.78	9.19	9.97	3.58	1.71	1.09	0.78	2.80	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	20.96	22.01	6.46	9.61	3.14	2.79	1.40	1.22	2.45	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	31.66	41.70	8.47	8.25	3.79	3.34	1.34	1.11	2.90	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	17.61	10.46	3.32	5.61	4.08	1.02	1.79	2.30	2.04	1.02
CD14-CD16+ Monocytes, donor2	11800-124C9	16.69	10.32	5.71	4.17	3.51	2.20	0.66	1.98	1.10	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	10.95	12.00	5.26	3.79	1.26	1.68	0.21	1.05	0.63	1.47
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	16.26	14.23	28.45	12.19	16.26	2.03	0.00	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	12.20	19.66	26.44	29.15	5.42	1.36	0.68	2.71	3.39	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	9.32	16.57	23.82	24.85	2.07	6.21	2.07	4.14	4.14	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	10.66	19.19	20.79	20.79	10.13	0.53	0.53	1.60	4.26	2.67
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	6.97	18.23	21.98	20.91	6.43	0.54	0.00	4.29	7.50	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	11.93	19.65	22.46	22.46	7.72	4.91	0.70	2.11	6.32	4.21
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	8.63	15.69	20.39	14.90	3.92	1.57	0.78	0.78	1.57	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	7.91	18.46	15.82	32.96	11.86	5.27	0.00	2.64	2.64	5.27
CD19+ B Cells, donor1	11544-120B5	36.16	20.55	19.73	20.55	9.04	2.47	0.00	5.75	7.40	2.47
CD19+ B Cells, donor2	11624-122B4	26.12	10.16	19.59	12.33	6.53	4.35	1.45	2.18	3.63	3.63
CD19+ B Cells, donor3	11705-123B4	23.73	23.22	22.72	18.17	5.05	1.51	2.02	2.52	6.56	5.55
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	7.68	5.25	0.40	0.00	0.81	1.21	0.00	0.00	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	2.00	5.19	0.40	0.80	0.00	0.00	0.00	0.40	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	18.07	4.02	5.02	7.03	3.01	1.00	0.00	3.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	30.90	0.56	5.06	2.81	2.25	2.25	0.56	0.56	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	6.01	5.64	11.27	5.64	1.88	1.88	1.88	1.88	4.51	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	7.44	4.28	12.18	8.12	1.80	2.71	2.25	1.80	2.93	0.45
CD4+ T Cells, donor1	11225-116C1	50.35	28.21	31.78	30.35	12.85	6.07	0.36	6.78	2.14	2.86
CD4+ T Cells, donor2	11306-117C1	45.93	15.92	22.66	25.11	6.12	5.51	0.00	2.45	0.61	1.84
CD4+ T Cells, donor3	11382-118B5	35.07	21.65	19.82	20.43	9.15	6.71	0.91	3.05	1.52	2.13
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	31.90	16.59	18.63	24.76	3.83	5.62	0.51	5.36	2.04	5.10
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	29.42	17.97	22.01	31.22	4.72	4.49	0.45	4.04	2.02	2.25
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	42.54	18.11	28.17	34.21	4.02	9.49	0.57	6.32	2.30	4.02
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	27.02	15.17	20.86	22.28	8.53	4.74	0.00	3.32	2.84	3.79
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	30.90	17.56	18.96	31.60	7.73	3.51	1.40	4.92	1.40	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	6.59	16.48	13.18	36.26	19.78	6.59	0.00	3.30	3.30	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	27.17	9.39	13.15	18.35	2.75	5.64	0.87	5.78	1.88	2.31
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	29.32	14.07	17.79	16.78	3.22	5.93	0.68	4.07	2.20	2.71
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	25.79	9.99	11.93	15.64	2.26	5.00	0.32	3.71	0.81	1.77
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	30.93	5.38	11.21	15.24	4.48	5.83	0.45	2.24	1.34	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	27.95	9.08	12.93	20.26	2.80	4.89	0.35	4.19	0.35	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	34.76	16.28	11.44	23.32	3.52	8.36	0.44	5.28	0.88	2.20
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	34.57	17.71	13.07	18.97	5.06	5.48	0.84	4.22	1.26	2.53
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	26.59	16.21	18.49	13.71	3.74	3.74	0.00	2.91	0.62	2.70
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	18.38	14.03	10.02	14.03	3.01	4.34	1.00	2.34	2.00	2.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	20.94	22.57	28.55	32.09	12.24	6.25	0.27	4.35	1.63	3.26
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	18.76	22.51	31.09	38.05	11.79	8.04	1.07	5.36	4.29	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	32.28	28.69	28.69	34.07	5.38	5.38	0.00	5.38	3.59	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	31.15	15.95	16.69	21.32	4.26	6.12	1.11	5.93	2.04	2.78
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	27.73	11.26	16.90	17.76	3.03	3.03	1.08	5.42	1.08	1.52
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	26.48	12.82	22.28	18.28	3.78	6.09	0.63	5.67	0.63	2.31
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	18.20	10.62	16.18	20.22	5.56	2.53	1.01	4.04	1.52	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	21.66	11.70	10.40	19.06	4.33	5.63	0.87	1.73	1.30	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	30.51	15.69	16.56	23.97	6.54	6.54	0.44	4.36	0.44	3.49
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	21.28	17.82	28.21	39.59	8.91	5.94	0.49	2.97	2.97	3.46
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	11.08	17.54	16.62	24.93	4.62	4.62	0.00	2.77	1.85	6.46
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	15.35	18.15	19.54	41.87	9.77	6.98	4.19	2.79	1.40	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	23.54	27.69	24.09	25.48	5.82	4.43	0.28	4.15	1.11	3.32
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	22.82	26.75	23.56	30.67	7.12	5.15	0.25	6.13	2.70	2.70
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	21.56	32.34	9.24	18.48	12.32	3.08	1.54	7.70	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	16.12	16.83	27.93	32.59	7.52	5.01	0.72	7.52	1.43	2.15
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	11.08	15.23	20.77	30.47	1.38	8.31	0.00	6.92	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	47.14	8.84	21.61	21.61	7.86	7.86	0.65	4.91	1.31	3.27
CD8+ T Cells, donor2	11307-117C2	44.30	5.26	13.52	19.52	6.38	12.39	0.75	5.26	0.38	2.63
CD8+ T Cells, donor3	11383-118B6	44.94	10.10	26.01	25.50	10.35	11.11	0.76	2.27	0.50	3.79
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	4.36	2.98	1.84	0.46	0.23	1.15	2.98	1.38	1.84	1.84
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	4.79	2.64	4.07	0.72	0.24	0.96	2.16	1.44	2.88	1.92
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	4.92	2.19	1.92	2.46	0.55	0.82	2.46	0.27	4.10	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	4.50	2.70	2.10	1.50	0.30	0.00	2.70	0.60	2.10	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	4.56	1.92	2.64	1.68	0.72	1.44	1.68	0.96	1.92	1.20
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	6.59	3.41	3.41	1.59	0.45	1.14	3.41	0.45	1.59	2.27
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	3.91	2.82	3.48	2.39	0.43	0.65	0.65	0.87	2.17	1.52
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	6.84	2.90	1.84	0.79	0.00	0.53	2.11	1.58	2.90	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	7.04	4.22	4.46	1.88	0.47	0.23	3.05	0.94	2.81	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	5.74	4.53	2.42	1.81	0.30	0.91	0.91	1.51	2.42	1.81
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	3.49	3.78	4.07	2.32	0.87	1.16	2.91	1.16	2.91	4.36
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	5.06	3.20	3.20	2.93	0.27	0.80	1.87	0.80	2.93	1.60
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	7.00	5.25	3.50	1.75	2.63	0.88	1.31	0.88	1.75	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	10.47	4.55	3.19	1.37	2.28	1.37	1.37	1.82	1.37	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	13.43	6.71	1.49	2.24	0.00	0.75	0.00	2.98	1.49	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	5.76	5.04	2.52	2.88	0.72	0.72	2.88	1.80	1.08	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	4.03	3.16	3.45	1.73	0.58	2.01	3.45	0.58	0.58	2.88
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	5.42	3.30	2.83	2.59	0.71	0.71	4.95	0.94	3.30	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	4.75	4.12	3.49	1.27	0.95	0.32	4.44	0.32	2.85	1.58
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	7.69	4.00	2.46	1.85	0.92	0.31	3.08	1.23	2.46	1.85
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	5.13	2.56	1.92	2.56	0.96	1.28	0.96	1.60	2.24	3.53
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	4.59	2.68	2.68	2.29	0.38	1.15	1.15	1.53	2.68	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	5.91	1.58	3.15	1.18	0.79	0.39	0.79	1.58	2.76	3.55
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	2.27	2.27	4.54	1.51	0.00	0.00	1.51	1.51	2.27	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	14.45	4.01	1.61	1.61	1.61	0.80	0.80	2.41	1.61	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	10.49	5.60	2.80	1.40	4.20	2.10	0.70	3.50	1.40	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	18.03	6.01	4.01	5.01	1.00	2.00	1.00	3.01	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	3.66	1.83	0.00	3.66	0.00	1.83	0.00	0.00	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	1.98	1.48	0.49	0.00	0.49	0.49	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	0.74	0.63	0.53	0.21	0.11	0.53	0.74	0.32	0.00	0.32
Chondrocyte - de diff, donor1	11261-116G1	2.08	2.77	0.35	0.35	0.35	0.00	0.35	0.35	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	2.49	1.78	2.49	0.00	0.36	0.00	0.00	1.07	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	2.50	1.48	0.68	0.23	0.91	0.68	0.11	0.91	0.46	0.57
Chondrocyte - re diff, donor2	11339-117F7	9.85	2.69	5.37	0.00	0.90	1.79	2.69	0.90	1.79	0.90
Chondrocyte - re diff, donor3	11411-118E7	6.47	2.02	0.81	0.00	0.81	1.62	0.40	1.62	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	2.98	1.72	4.36	0.69	1.72	1.61	1.84	1.15	0.80	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	3.63	0.21	2.35	0.64	0.86	0.64	1.07	0.21	0.21	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	4.42	0.71	2.65	1.15	1.59	1.15	0.71	0.97	0.44	0.80
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	15.41	8.53	5.59	2.02	4.40	3.30	4.68	3.21	1.28	1.10
Corneal Epithelial Cells, donor1	11526-119I5	14.49	8.12	3.07	1.76	3.51	1.76	3.73	2.20	1.54	1.54
Corneal Epithelial Cells, donor2	11606-120I4	6.83	5.69	4.55	0.00	3.41	5.69	2.28	5.69	0.00	2.28
Corneal Epithelial Cells, donor3	11687-122I4	5.88	3.07	1.79	1.28	1.02	1.53	1.28	1.53	0.26	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	11.06	10.07	1.32	2.81	0.83	0.66	0.66	0.17	1.49	0.66
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	10.09	11.99	1.89	1.89	0.63	0.32	1.58	0.63	1.58	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	6.90	3.45	3.45	0.00	0.00	0.00	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	7.24	7.99	2.27	1.94	0.54	0.22	1.08	0.22	0.86	1.40
Dendritic Cells - plasmacytoid, donor1	11228-116C4	10.25	5.12	13.67	5.47	3.76	2.05	0.68	2.73	0.00	2.39
Dendritic Cells - plasmacytoid, donor2	11309-117C4	14.36	1.96	6.53	7.18	1.31	3.92	0.65	1.31	0.00	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	16.94	2.90	4.36	6.29	0.48	2.42	0.48	1.45	0.48	1.94
Endothelial Cells - Aortic, donor0	11207-116A1	3.50	4.17	2.67	1.33	2.00	0.67	0.83	1.67	0.67	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	2.35	1.76	3.52	1.17	0.00	0.59	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	8.48	3.68	4.24	0.57	0.85	0.85	1.13	1.13	1.70	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	6.29	3.15	3.54	1.97	0.79	1.18	0.79	1.57	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	4.94	2.62	2.33	0.58	0.58	0.29	0.00	0.00	0.29	0.29
Endothelial Cells - Artery, donor2	11341-117F9	9.41	2.82	5.18	1.88	0.94	1.41	1.18	0.94	1.18	0.24
Endothelial Cells - Artery, donor3	11413-118E9	7.71	3.16	2.80	1.75	1.05	1.05	0.88	1.05	0.70	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	9.75	3.10	1.11	0.66	0.66	0.66	0.89	0.66	0.44	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	8.22	4.26	2.74	0.30	0.61	0.61	0.30	0.61	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	14.94	6.48	5.07	2.54	2.26	0.56	0.56	0.85	0.56	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	8.62	2.97	1.19	0.59	0.30	0.30	0.59	0.59	1.19	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	5.21	4.17	1.04	1.04	0.52	2.08	1.56	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	11.91	4.25	4.25	1.56	0.99	1.13	0.14	0.99	1.13	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	8.40	4.40	1.20	0.40	0.40	1.20	0.00	0.00	1.20	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	6.81	3.67	3.67	1.57	1.57	0.52	0.52	1.05	0.52	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	9.44	4.85	2.98	0.99	0.62	1.99	0.99	1.37	0.62	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	9.13	4.13	3.48	1.52	1.74	1.74	0.22	1.30	0.65	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	7.82	4.40	2.93	1.10	1.34	0.85	0.37	0.37	0.73	0.61
Endothelial Cells - Vein, donor1	11267-116G7	6.83	4.55	5.69	2.28	2.28	1.14	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	5.59	1.40	4.19	6.29	1.40	1.40	0.70	2.10	1.40	0.70
Endothelial Cells - Vein, donor3	11416-118F3	5.97	4.08	3.30	1.88	1.41	1.10	0.79	0.47	1.10	0.94
Eosinophils, donor1	12244-129H3	15.25	15.25	15.25	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	282.19	28.05	19.80	36.31	42.91	1.65	0.00	3.30	0.00	4.95
Eosinophils, donor3	12246-129H5	149.81	28.53	7.13	14.27	39.24	0.00	0.00	0.00	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	10.02	2.93	2.69	0.49	1.22	0.98	2.44	0.49	0.49	1.22
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	10.40	4.16	0.00	0.00	0.00	0.00	2.08	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	2.87	1.23	0.00	0.00	0.41	0.41	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	0.44	0.00	0.33	0.11	0.22	0.22	0.00	0.22	0.33	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	1.19	0.54	0.76	0.00	0.11	0.11	0.11	0.11	0.33	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	0.85	0.49	0.85	0.12	0.61	0.36	0.36	0.36	0.24	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	3.82	0.82	0.96	0.14	0.27	0.68	0.14	0.41	0.27	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	1.58	1.16	0.84	0.32	0.42	0.11	0.11	0.21	0.42	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	3.16	2.37	0.79	0.00	0.79	0.53	0.53	0.53	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	1.99	1.66	1.33	0.33	1.00	0.66	0.33	0.00	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	2.27	1.36	0.91	0.45	0.45	0.91	0.00	0.45	0.45	1.81
Fibroblast - Cardiac, donor2	11345-117G4	3.79	3.03	0.76	0.76	1.52	0.76	0.00	2.27	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	2.37	2.21	2.05	0.63	0.63	0.79	1.26	0.16	0.32	1.10
Fibroblast - Cardiac, donor4	11452-119A3	3.33	2.73	1.82	0.00	0.00	0.30	0.61	0.00	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	4.57	2.54	1.14	0.38	0.89	0.51	0.51	0.51	0.38	0.00
Fibroblast - Cardiac, donor6	11460-119B2	3.64	1.52	0.76	0.00	0.15	0.15	0.30	0.45	0.30	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	6.03	3.08	1.61	1.07	1.07	0.54	0.54	1.47	0.40	1.74
Fibroblast - Choroid Plexus, donor2	11572-120E6	3.88	1.73	0.00	0.00	1.29	0.43	0.43	0.86	0.00	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	4.39	2.93	2.93	1.46	1.46	0.00	0.00	0.00	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	6.92	1.85	1.15	0.69	0.92	0.46	0.69	1.15	0.23	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	4.41	1.70	1.70	0.34	1.02	1.36	1.36	0.17	0.17	0.85
Fibroblast - Dermal, donor1	11269-116G9	1.64	0.94	0.47	0.47	0.23	1.17	0.00	0.94	0.70	0.47
Fibroblast - Dermal, donor2	11346-117G5	1.42	3.30	0.47	0.00	0.00	0.00	0.00	0.00	1.42	0.00
Fibroblast - Dermal, donor3	11418-118F5	2.54	2.30	0.12	0.24	0.12	0.48	0.36	0.36	0.12	0.73
Fibroblast - Dermal, donor4	11450-119A1	1.47	1.13	1.13	0.68	0.11	0.34	0.68	0.45	0.68	0.34
Fibroblast - Dermal, donor5	11454-119A5	1.22	0.52	1.05	0.17	0.00	0.17	0.35	0.35	0.87	0.17
Fibroblast - Dermal, donor6	11458-119A9	1.14	1.62	0.81	0.32	0.00	0.81	0.65	1.14	1.14	0.16
Fibroblast - Gingival, donor1	11237-116D4	2.71	1.46	1.25	0.00	0.00	0.00	0.00	0.83	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	3.41	1.57	0.26	0.00	0.26	0.52	0.00	0.26	0.52	0.26
Fibroblast - Gingival, donor2	11318-117D4	2.50	1.45	0.79	0.53	0.26	0.66	0.13	0.13	0.40	0.66
Fibroblast - Gingival, donor3	11394-118C8	3.96	2.42	0.77	0.00	0.87	0.68	0.29	0.19	0.68	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	4.16	2.08	1.04	0.00	1.04	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	3.00	2.29	0.18	0.00	0.53	0.35	0.00	0.53	0.18	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	0.78	0.94	0.47	0.00	0.00	0.16	0.16	0.16	0.31	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	2.16	1.35	0.81	0.00	0.27	0.27	0.14	0.41	0.14	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	9.53	5.29	1.76	0.35	0.71	0.00	0.71	0.35	0.00	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	2.78	1.17	0.73	0.15	0.15	0.15	0.00	0.29	0.00	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	1.64	1.77	0.00	0.14	0.14	0.27	0.27	0.27	0.00	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	1.76	0.66	0.44	0.00	0.22	0.88	0.00	0.11	0.33	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	3.82	2.93	1.32	0.00	0.88	0.73	0.44	1.03	0.88	0.88
Fibroblast - Lung, donor1	11270-116H1	5.44	2.72	1.36	0.00	2.72	1.36	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	10.45	7.46	2.98	0.00	1.49	0.00	1.49	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	2.53	0.84	2.53	0.42	0.42	0.63	0.84	0.42	0.42	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	9.16	7.50	1.67	2.50	0.83	1.67	1.67	1.67	0.83	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	2.80	0.00	0.00	1.40	0.00	0.00	0.00	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	4.76	1.12	0.84	0.00	0.00	0.56	0.28	0.56	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	5.68	4.06	2.03	0.41	1.22	1.22	1.22	1.62	1.22	0.41
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	1.36	0.97	0.97	0.00	0.19	0.78	0.78	0.39	0.39	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	3.94	1.21	2.43	0.46	1.06	0.76	1.37	0.91	1.06	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	4.59	2.75	1.53	0.00	0.61	0.00	0.00	0.61	0.61	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	3.82	1.91	0.38	0.00	0.00	0.38	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	0.54	0.81	0.00	0.27	0.27	0.81	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	1.39	2.32	0.93	0.00	0.46	0.23	0.12	0.00	0.12	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	1.77	0.88	0.66	0.33	0.22	0.11	0.66	0.11	0.11	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	8.53	2.03	1.22	0.41	0.61	0.61	0.20	1.42	0.81	1.22
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	2.00	2.00	0.00	0.00	0.00	0.00	0.00	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	1.58	0.00	0.00	0.00	1.19	0.00	0.00	0.00	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	4.37	1.39	0.79	0.20	0.20	0.40	0.20	1.39	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	1.95	1.42	0.71	0.00	0.53	0.00	0.00	0.00	0.00	1.07
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	1.58	1.18	0.20	0.00	0.00	0.39	0.00	0.39	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	1.81	2.71	0.30	0.30	0.00	0.00	0.00	0.30	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	1.84	1.19	0.65	0.11	0.11	0.22	0.22	0.43	0.00	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	4.30	2.78	0.51	0.00	0.25	0.25	0.25	0.51	0.51	0.25
Fibroblast - skin normal, donor1	11553-120C5	2.13	1.48	0.82	0.00	0.16	0.33	0.33	0.16	0.16	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	3.01	1.20	1.20	0.00	0.40	0.40	0.40	1.20	0.00	0.40
Fibroblast - skin normal, donor2	11561-120D4	2.71	1.51	0.50	0.20	0.20	0.20	0.30	0.40	0.30	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	3.32	2.12	0.91	0.00	0.30	0.30	0.30	0.91	0.00	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	2.15	0.99	0.83	0.17	0.08	0.41	0.25	0.66	0.17	0.50
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	2.91	2.39	0.68	0.17	0.34	0.17	0.68	0.00	0.68	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	3.61	2.30	0.66	0.00	0.33	0.00	0.66	0.66	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	2.56	1.81	0.64	0.11	0.11	0.43	0.00	0.43	0.21	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	1.35	1.18	0.51	0.00	0.34	0.00	0.17	0.51	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	0.47	1.10	0.31	0.00	0.16	0.00	0.00	0.16	0.00	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	5.23	6.10	3.49	0.87	0.00	2.61	0.00	2.61	1.74	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	7.11	5.20	4.16	1.73	1.56	1.73	0.52	1.91	0.35	1.39
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	12.23	4.68	2.86	0.52	1.56	1.56	0.78	2.34	1.04	1.30
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	6.39	6.39	3.83	1.28	2.56	2.81	1.53	2.04	0.51	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	10.72	8.42	26.79	6.12	2.30	5.36	17.61	3.83	3.83	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	10.85	3.19	28.08	6.38	1.28	5.74	9.57	4.47	2.55	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	17.12	6.28	37.37	6.28	9.98	10.55	4.28	4.85	5.13	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	17.92	9.38	38.05	4.41	4.41	8.55	8.82	6.62	1.38	1.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	14.38	4.57	18.04	2.97	5.25	7.53	7.31	5.48	1.83	1.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	14.07	8.92	37.05	5.94	7.13	7.93	6.34	4.76	2.77	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	14.80	9.52	31.72	6.08	5.55	5.02	11.90	4.76	1.85	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	12.07	6.52	20.87	3.26	6.20	5.54	5.54	5.22	1.96	2.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	16.36	3.54	22.11	6.19	6.19	7.96	8.84	2.65	5.31	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	17.81	6.92	30.67	7.07	6.22	7.21	11.87	4.52	4.24	1.27
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	15.39	6.40	20.32	5.66	7.88	4.56	9.61	3.94	2.59	1.35
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	15.04	6.18	26.59	7.79	5.64	6.98	13.70	3.76	4.03	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	17.59	7.68	18.71	4.96	8.30	4.83	8.42	2.85	3.10	1.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	20.07	8.86	19.24	7.20	8.58	4.71	9.00	2.21	3.60	1.66
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	14.64	9.35	15.65	5.90	4.88	5.08	4.88	2.44	3.05	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	12.32	8.90	11.64	5.70	3.19	4.34	5.02	1.83	1.14	2.05
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	16.19	6.35	12.83	3.61	6.60	3.11	6.10	3.61	2.49	1.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	21.86	13.99	17.27	5.90	5.90	3.93	5.90	1.09	1.97	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	10.93	8.27	10.05	3.25	2.66	3.25	5.02	2.07	1.18	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	14.47	6.20	14.62	4.77	5.56	4.29	7.31	3.02	2.54	1.27
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	19.66	7.15	16.09	4.24	8.94	3.35	7.15	2.90	2.46	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	8.87	7.26	9.88	3.43	4.84	4.03	5.24	3.02	1.81	1.61
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	10.35	5.43	9.50	1.87	3.39	2.88	5.09	3.05	3.05	2.04
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	18.09	8.34	12.41	2.48	5.85	4.52	6.03	4.26	1.24	2.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	20.39	15.92	21.23	5.93	8.32	7.91	9.47	9.47	3.23	4.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	13.83	16.57	17.08	5.46	6.83	6.32	6.66	5.81	4.10	5.46
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	8.30	5.86	11.29	2.88	4.98	3.98	4.20	3.54	1.44	1.99
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	8.90	5.91	9.98	2.50	4.08	4.99	4.66	5.41	1.16	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	9.19	7.35	7.35	1.23	3.27	4.29	4.08	3.06	1.02	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	7.43	5.98	9.90	2.06	4.13	3.92	4.13	3.30	0.83	2.89
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	10.15	6.80	13.49	2.54	4.15	4.50	3.34	4.04	2.31	3.11
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	7.17	4.84	8.17	2.33	2.33	2.33	4.67	4.50	0.83	3.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	8.16	6.39	11.68	2.87	2.65	4.63	3.53	3.09	1.32	1.54
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	10.33	6.89	10.82	4.30	6.03	5.17	3.94	3.20	1.97	2.58
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	8.59	6.32	10.21	2.27	2.92	3.40	3.73	4.54	1.30	2.59
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	13.47	8.34	13.15	3.53	3.85	5.45	3.53	4.81	3.21	2.25
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	7.96	5.40	8.91	3.13	3.32	3.22	3.41	1.80	1.61	2.46
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	7.12	4.11	6.33	2.53	2.06	5.38	4.27	1.90	0.79	2.53
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	9.43	7.91	4.26	2.13	1.22	3.04	3.34	3.95	0.91	2.13
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	9.72	4.70	7.11	2.82	3.24	3.14	3.14	2.61	1.36	1.88
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	5.93	5.27	5.27	2.63	2.63	3.51	1.54	1.76	1.10	1.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	5.61	6.45	8.98	0.84	1.96	3.65	3.37	2.24	1.12	2.52
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	6.48	2.50	5.83	2.87	1.85	2.78	2.96	1.76	1.11	3.33
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	5.08	2.41	1.34	0.53	0.53	2.41	1.07	1.34	0.53	1.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	3.37	2.45	1.68	1.99	1.07	1.53	1.99	2.14	1.22	1.84
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	5.05	2.20	2.46	2.07	0.78	1.68	2.59	1.17	0.91	1.68
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	5.42	3.52	1.08	1.63	1.90	1.08	1.36	1.08	0.54	2.17
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	6.08	2.77	4.98	2.40	2.03	3.50	1.84	1.66	1.11	2.58
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	6.14	4.17	5.04	1.32	0.88	2.85	1.97	3.07	1.75	1.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	18.84	10.91	14.88	1.98	8.93	2.98	4.96	0.99	1.98	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	4.49	2.37	2.51	1.06	0.92	1.71	1.32	1.32	0.79	2.11
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	4.64	3.03	2.42	1.41	1.61	1.21	0.40	1.21	0.61	1.41
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	38.38	22.87	12.96	3.30	9.91	4.83	5.85	6.61	3.81	5.08
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	19.71	8.16	25.28	6.97	6.37	5.97	11.94	4.38	4.98	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	29.58	5.70	36.05	8.78	8.01	10.17	16.49	3.70	4.31	2.16
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	24.96	5.73	44.80	13.50	10.23	11.25	19.03	6.14	5.73	1.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	4.69	3.44	14.08	4.38	3.13	4.69	2.82	2.50	1.25	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	5.09	1.41	15.54	2.54	1.13	5.09	4.24	1.41	1.13	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	9.22	2.31	17.06	4.15	1.84	4.61	5.53	1.84	1.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	9.90	2.47	19.80	7.42	0.00	2.47	9.90	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	12.38	5.03	25.53	6.19	6.58	8.12	8.51	2.71	3.87	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	14.44	1.60	28.88	4.81	3.21	6.42	16.04	8.02	3.21	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	5.22	5.22	19.13	6.96	13.91	10.43	10.43	3.48	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	4.23	3.91	16.60	3.25	7.49	3.91	6.51	2.28	2.93	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	10.71	3.71	18.12	4.12	6.18	5.77	3.71	4.12	4.12	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	3.33	0.00	26.66	0.00	6.66	6.66	3.33	3.33	13.33	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	4.47	2.80	14.26	2.80	2.80	2.24	6.43	1.96	2.24	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	5.56	4.25	13.40	3.27	3.60	5.88	4.58	3.92	4.58	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	3.36	5.03	16.78	4.19	4.19	4.19	7.55	5.03	4.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	4.77	5.73	15.90	1.27	3.18	4.77	4.77	4.77	2.23	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	6.79	5.43	14.95	2.38	3.40	4.42	7.13	2.04	2.04	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	2.09	4.18	10.44	0.00	2.09	2.09	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	6.87	9.74	15.46	2.29	1.72	6.30	6.30	2.29	1.72	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	2.66	4.14	10.66	1.78	2.96	2.07	5.92	2.37	0.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	3.39	3.39	15.25	0.00	1.69	0.00	5.08	3.39	1.69	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	5.80	4.56	11.60	3.31	3.73	2.49	5.38	2.07	3.73	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	4.14	5.75	12.66	1.15	2.99	4.60	6.44	2.99	1.61	2.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	0.00	10.54	0.00	0.00	5.27	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	3.08	3.46	8.84	1.15	0.77	2.69	3.08	3.84	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	2.61	2.28	4.24	0.98	1.30	2.61	2.61	1.30	0.65	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	1.34	1.34	8.03	0.67	2.01	2.01	1.34	2.01	2.01	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	8.48	8.09	11.17	1.54	3.85	3.47	7.32	1.93	0.39	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	6.85	7.87	12.32	0.68	2.74	4.79	6.16	4.45	2.74	4.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	9.94	12.42	12.42	4.97	9.94	2.48	2.48	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	5.19	6.13	18.40	1.89	5.66	5.19	3.77	4.72	0.94	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	3.02	6.03	6.03	0.00	3.02	3.62	1.21	4.22	1.21	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	6.61	4.58	9.66	1.53	3.05	2.54	4.58	5.60	0.51	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	4.39	8.77	14.36	3.59	5.98	3.59	2.79	3.19	1.20	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	6.41	6.41	6.91	0.49	2.96	1.48	1.48	4.44	2.96	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	3.54	4.72	11.80	5.90	2.36	2.36	3.54	4.72	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	5.25	3.50	14.00	1.17	3.50	2.92	1.17	1.75	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	7.46	8.34	12.73	0.88	4.39	3.07	2.19	2.63	0.44	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	6.78	6.78	17.80	0.85	2.54	5.09	3.39	4.24	4.24	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	3.58	4.18	7.16	0.60	2.39	1.79	1.79	4.78	1.19	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	4.85	5.82	4.37	1.46	1.46	2.91	2.43	1.46	0.97	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	2.28	1.14	1.14	1.14	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	2.49	1.66	0.83	0.00	0.42	0.42	0.00	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	3.37	0.00	0.00	0.00	0.00	1.12	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	2.85	0.95	0.32	0.63	0.32	0.32	0.00	0.63	1.27	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	0.84	2.09	0.00	0.00	0.42	0.00	0.00	0.00	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	0.93	2.32	0.81	0.35	0.58	0.70	1.04	0.81	0.46	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	0.51	3.54	0.84	0.51	0.00	0.34	1.69	0.51	0.51	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	0.68	2.28	1.14	0.00	0.00	1.59	1.37	0.46	0.23	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	1.20	1.31	1.42	0.44	0.33	0.66	2.08	0.33	1.31	0.77
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	0.86	2.58	1.07	0.43	0.21	0.21	1.50	0.43	0.86	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	0.86	1.94	2.15	0.00	0.22	0.43	1.72	0.22	0.65	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	1.00	1.62	1.12	0.50	0.50	0.87	1.74	0.75	0.75	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	1.37	2.40	1.20	0.17	0.00	1.03	0.69	0.69	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	0.64	1.60	0.32	0.32	0.00	1.28	0.64	0.00	0.64	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	10.63	4.48	2.80	1.68	1.12	0.56	1.12	0.00	1.12	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	7.36	4.76	3.03	1.30	0.87	2.16	0.87	1.73	1.73	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	10.58	5.29	0.00	0.00	0.00	0.00	0.00	2.64	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	2.47	1.41	2.47	0.00	0.71	1.41	0.35	1.06	0.35	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	4.36	1.45	0.00	0.73	1.45	0.00	0.73	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	2.45	1.57	0.70	0.35	0.35	0.17	0.35	0.00	0.17	0.35
Hepatocyte, donor1	11523-119I2	1.21	3.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	4.31	10.77	2.15	1.08	3.23	0.00	0.00	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	2.45	7.98	0.61	0.61	0.61	0.00	0.00	0.61	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	1.96	9.14	24.80	22.19	3.26	5.22	0.00	5.87	3.26	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	10.14	10.14	8.39	1.75	3.85	3.67	9.09	4.54	1.92	2.27
Iris Pigment Epithelial Cells, donor1	11530-119I9	2.47	1.78	1.10	0.41	0.41	0.69	0.82	0.41	0.41	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	0.00	3.18	0.00	0.00	0.00	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	6.68	0.00	0.00	6.68	6.68	0.00	6.68	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00	0.00	0.00	0.00	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	8.31	5.54	5.54	2.77	4.15	1.38	6.92	1.38	1.38	4.15
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	0.00	5.01	2.50	7.51	2.50	0.00	0.00	10.01	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	11.87	0.00	0.00	0.00	0.00	0.00	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	15.38	10.25	5.13	2.56	0.00	2.56	7.69	0.00	5.13	5.13
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	9.14	4.57	0.00	0.00	0.00	0.00	0.00	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	14.62	6.50	12.99	4.87	0.00	4.87	3.25	3.25	3.25	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	8.34	5.00	3.33	1.67	3.33	0.00	3.33	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	0.00	10.89	0.00	0.00	3.63	0.00	0.00	3.63	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	18.53	5.29	9.26	2.65	6.62	2.65	6.62	3.97	7.94	5.29
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	6.65	4.43	5.54	0.00	1.11	1.11	3.33	2.22	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	0.00	5.24	0.00	0.00	5.24	0.00	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	13.86	4.41	8.19	4.41	2.52	1.89	6.30	1.26	3.15	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	12.37	12.37	10.83	4.64	3.09	0.00	1.55	1.55	3.09	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	16.15	4.52	10.34	3.88	1.94	3.88	3.88	1.29	3.88	4.52
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	14.49	8.05	3.22	1.61	1.61	1.61	3.22	1.61	4.83	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	11.95	0.00	11.95	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	10.59	2.44	10.59	4.07	1.63	4.07	8.96	1.63	0.81	3.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	12.59	4.62	11.33	3.36	2.94	2.52	4.62	1.68	2.94	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	21.70	1.61	6.43	3.21	4.02	0.00	9.64	0.00	7.23	3.21
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	4.62	0.92	3.69	0.00	2.77	0.00	1.85	0.00	1.85	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	15.08	0.00	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	6.61	2.83	2.83	3.30	2.36	0.00	5.66	1.42	2.83	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	10.88	2.72	3.63	0.91	2.72	0.91	0.91	0.00	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	12.91	1.08	4.30	2.15	0.00	1.08	6.46	1.08	3.23	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	6.35	5.08	8.89	0.00	2.54	1.27	3.81	2.54	3.81	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	10.20	5.74	2.55	3.83	5.10	0.00	1.91	0.64	3.19	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	5.47	1.82	0.00	1.82	0.00	1.82	7.29	0.00	3.65	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	31.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	11.43	4.28	6.43	2.14	1.43	3.57	3.57	0.00	1.43	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	9.95	6.64	0.00	6.64	0.00	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	20.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	7.72	1.85	2.78	0.93	0.93	0.31	3.09	0.00	1.23	1.54
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	14.05	0.00	5.27	7.02	3.51	3.51	5.27	0.00	3.51	3.51
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	3.14	9.43	0.00	3.14	3.14	3.14	3.14	3.14	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	11.13	4.17	9.04	7.65	1.39	4.17	0.70	2.09	5.56	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	17.70	0.00	15.49	6.64	2.21	2.21	6.64	2.21	2.21	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	3.24	6.48	3.24	0.00	0.00	3.24	3.24	6.48	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	20.05	2.62	14.82	3.49	9.59	1.74	1.74	0.87	1.74	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	13.50	6.75	9.00	2.25	9.00	0.00	2.25	4.50	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	3.48	0.00	0.00	6.97	3.48	0.00	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	12.80	6.40	11.73	1.07	13.87	4.27	5.33	2.13	4.27	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	15.24	8.31	4.16	1.39	5.54	1.39	5.54	0.00	4.16	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	5.70	19.95	0.00	2.85	0.00	11.40	0.00	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	10.12	5.52	17.49	11.05	1.84	0.92	6.44	0.92	0.92	2.76
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	24.20	9.08	3.03	3.03	15.13	0.00	3.03	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	12.42	6.21	12.42	6.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	13.75	5.29	12.69	2.11	13.75	4.23	0.00	3.17	2.11	2.11
Keratinocyte - epidermal, donor1	11272-116H3	9.87	3.84	4.57	0.82	0.49	1.39	1.47	1.55	1.06	1.47
Keratinocyte - epidermal, donor2	11349-117G8	7.03	4.10	2.34	0.59	0.00	1.17	0.59	1.76	0.00	1.76
Keratinocyte - epidermal, donor3	11421-118F8	5.21	2.84	2.84	0.47	0.85	1.51	1.61	1.23	0.19	1.33
Keratinocyte - oral, donor1	11251-116E9	15.44	5.56	7.83	2.61	3.29	2.84	5.45	2.95	1.70	2.27
Keratocytes, donor1	11527-119I6	6.53	2.06	1.03	0.34	1.38	0.69	1.72	0.69	0.69	0.69
Keratocytes, donor2	11607-120I5	1.17	1.17	1.17	0.00	0.00	1.17	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	4.74	1.98	0.20	0.59	1.19	0.79	1.38	0.40	0.20	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	10.99	6.59	6.59	2.20	6.59	4.40	6.59	4.40	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	0.00	0.00	0.00	0.00	0.00	0.00	2.16	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	3.58	1.38	3.46	0.46	2.54	0.58	1.38	1.38	0.46	1.27
Lens Epithelial Cells, donor3	11690-122I7	4.44	2.22	2.32	1.41	1.21	0.30	0.61	0.91	0.81	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	9.84	3.32	3.44	1.07	1.54	1.42	0.47	0.71	0.95	0.59
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	9.49	1.40	1.95	0.84	0.28	0.84	0.56	0.56	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	8.82	4.09	3.46	1.26	0.31	1.42	0.16	0.79	0.63	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	5.91	0.54	2.69	1.61	0.54	1.08	0.00	0.54	0.54	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.35	3.15	5.04	0.95	0.95	0.00	0.63	0.63	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.65	2.80	2.59	0.86	1.29	0.75	0.54	0.86	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	8.62	0.41	2.87	1.23	1.23	0.41	0.41	0.41	2.05	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	11.12	2.28	2.78	0.51	0.51	0.51	0.25	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	8.87	1.97	1.83	0.70	1.55	0.84	0.42	0.56	0.70	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	6.72	2.37	1.98	0.79	0.79	0.40	0.00	0.40	1.58	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	7.56	1.94	1.16	0.39	0.78	0.78	0.58	0.58	0.39	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.22	2.59	2.59	1.30	0.74	0.56	0.00	1.11	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	5.92	2.09	1.74	0.35	1.74	0.35	0.35	0.35	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	6.92	2.86	3.10	0.95	0.72	0.95	0.00	0.24	0.72	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.18	3.16	1.65	0.82	0.69	0.82	0.41	0.41	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	9.85	1.54	1.23	0.62	2.16	1.23	0.00	0.62	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	5.61	2.81	0.00	0.94	0.31	0.62	0.31	0.62	0.94	1.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	12.81	2.74	1.65	1.28	1.10	0.91	0.18	1.10	1.10	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	6.91	2.30	0.66	0.99	0.99	0.66	0.33	0.33	0.99	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.61	1.17	1.46	1.76	0.29	1.17	0.29	0.59	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	6.72	1.49	1.24	2.24	1.24	1.00	0.25	0.50	0.50	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	8.24	1.45	0.97	0.97	1.45	0.48	0.97	0.48	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	8.08	1.62	2.96	0.81	0.81	0.27	0.54	1.08	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	8.33	1.82	2.57	0.61	1.21	0.76	0.30	0.15	1.06	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	7.26	2.07	1.04	0.52	0.52	0.00	0.00	0.00	2.07	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	8.38	2.51	2.51	0.21	1.26	0.84	0.42	0.00	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	9.62	2.41	1.50	1.20	0.60	0.90	0.60	0.90	0.75	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	8.94	2.75	0.69	0.69	2.06	1.38	0.00	0.69	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	8.28	2.07	1.88	0.94	0.94	0.75	0.94	0.56	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	8.06	2.97	2.44	1.06	0.85	0.74	0.42	0.64	0.42	0.53
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	9.69	1.94	3.39	1.45	0.97	1.45	0.48	1.45	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	8.60	0.66	1.98	0.66	1.98	1.32	0.66	0.33	1.32	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	9.29	3.22	2.23	1.24	0.50	0.74	0.62	0.74	0.62	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	7.03	3.33	4.07	1.48	1.85	0.37	0.37	0.74	1.11	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	6.92	1.48	1.24	0.74	0.00	0.49	0.25	0.25	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.29	3.44	2.47	0.69	0.96	1.10	0.41	0.41	0.82	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	9.97	3.22	2.57	0.96	1.29	0.64	0.96	0.32	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	10.96	2.43	4.26	0.61	2.43	0.91	0.61	1.22	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	8.68	1.68	4.34	1.26	0.84	0.70	0.42	0.84	0.70	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	9.24	1.78	2.84	1.42	0.36	1.42	1.07	0.71	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	9.21	2.91	1.45	0.00	1.45	0.97	0.00	1.45	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	10.74	2.33	3.42	0.78	0.16	1.40	0.62	0.62	1.56	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	6.09	0.36	1.79	0.00	0.72	0.72	0.36	0.36	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	6.86	2.61	1.63	0.33	1.96	1.31	0.65	1.63	0.00	1.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	8.95	4.24	3.30	1.18	0.00	0.71	0.47	0.47	0.71	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	8.66	2.85	2.48	1.36	0.74	0.87	0.12	0.50	0.87	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.68	1.28	2.56	1.02	0.51	0.26	1.02	1.28	0.51	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.37	1.79	2.09	0.30	0.90	0.30	0.90	0.60	0.30	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	0.00	4.53	9.06	0.00	4.53	6.80	4.53	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	6.14	5.37	14.58	0.00	3.07	3.84	3.84	3.07	0.77	3.84
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	5.20	6.68	5.20	0.74	2.23	0.00	1.48	1.48	0.74	2.97
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	2.96	10.16	12.69	2.54	2.54	2.54	1.27	0.85	1.27	3.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	2.81	8.44	7.03	0.00	2.11	2.11	3.52	2.11	2.81	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	3.74	8.41	11.21	1.87	0.00	0.00	6.54	3.74	0.93	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	7.73	5.67	7.21	1.55	1.55	1.55	2.58	0.52	2.06	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	2.38	7.14	9.52	2.38	1.19	2.38	0.00	0.00	4.76	4.76
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	2.94	9.05	11.31	0.90	2.49	1.13	4.30	2.49	2.04	2.71
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	3.78	9.02	9.89	0.58	1.16	0.87	2.33	2.04	1.74	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	4.05	8.55	6.75	0.90	0.90	0.90	3.15	1.80	2.25	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	5.96	10.57	15.04	1.90	2.98	2.57	6.50	2.17	1.90	2.98
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	4.11	8.73	10.78	0.51	1.54	1.03	6.68	1.03	0.51	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	2.47	9.88	10.23	0.35	2.12	1.76	2.82	1.41	2.47	3.88
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	1.33	8.66	7.33	1.33	0.67	0.67	4.66	2.67	1.33	4.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	3.57	15.28	7.13	2.04	1.02	1.53	3.06	0.51	4.58	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	4.80	9.34	10.14	0.80	1.87	0.80	3.20	1.07	2.13	3.74
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	4.53	11.34	10.39	0.19	1.70	0.94	3.02	1.32	2.83	2.27
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	6.75	4.91	9.82	3.07	1.84	0.61	2.45	3.07	3.07	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	5.71	12.23	11.42	1.63	0.82	1.63	6.52	0.82	3.26	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	5.83	5.62	8.33	1.87	1.46	1.67	3.96	2.50	1.87	2.50
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	5.04	4.48	8.41	0.56	3.08	0.84	2.80	1.96	1.12	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	6.18	10.30	13.39	0.00	2.06	0.00	4.12	1.03	3.09	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	6.39	6.97	9.58	2.03	1.74	1.45	3.19	2.32	2.03	2.03
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	3.59	3.89	7.47	0.90	1.20	1.79	1.20	1.79	1.79	2.99
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	4.43	7.75	5.53	2.21	0.00	0.00	2.77	0.55	2.21	6.09
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	5.66	12.37	13.08	1.06	2.83	0.71	5.66	2.12	2.83	2.83
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	7.38	10.33	5.90	1.84	0.74	1.84	3.69	2.21	1.84	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	3.45	8.06	3.45	0.00	1.15	1.15	2.30	2.30	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	5.37	10.36	10.36	1.92	1.54	2.69	6.14	2.30	2.30	3.45
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	6.23	8.49	7.93	2.26	3.40	1.70	2.83	2.83	2.26	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	5.74	7.38	5.74	1.64	1.64	0.82	4.92	0.82	3.28	4.10
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	3.16	9.49	7.68	1.36	2.26	1.81	4.07	0.45	1.81	3.62
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	3.59	7.90	6.46	2.15	2.15	0.72	7.18	2.15	2.87	2.87
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	3.73	13.44	9.71	0.75	2.24	0.75	3.73	2.24	1.49	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	4.09	10.40	10.78	0.74	1.86	0.74	5.95	1.49	3.34	2.97
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	2.15	7.75	6.46	0.00	0.86	1.29	3.45	1.29	0.86	1.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	4.28	7.71	5.99	0.86	1.71	1.71	4.28	2.57	0.86	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	3.66	9.00	8.33	0.67	1.33	0.33	3.00	1.00	0.67	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	3.62	9.65	13.27	0.00	2.41	0.60	1.81	0.60	1.81	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	1.42	9.24	7.82	0.00	2.84	1.42	2.84	0.00	2.13	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	5.84	8.59	11.00	1.03	2.75	1.37	3.09	0.69	2.41	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	2.68	11.81	5.90	1.61	3.76	1.07	1.61	0.54	1.61	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	2.69	12.79	6.73	2.02	1.35	0.67	2.69	1.35	0.67	2.02
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	3.70	14.45	8.15	0.00	3.33	1.11	2.96	1.85	1.11	3.70
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	6.98	8.14	3.49	0.00	0.00	1.16	0.00	0.00	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	6.35	9.52	9.52	0.00	4.23	0.00	1.06	1.06	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	6.40	14.01	7.60	0.40	3.20	0.40	2.80	1.60	2.80	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	8.00	15.26	12.36	2.18	5.09	2.91	2.91	1.45	0.00	2.91
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	6.90	6.13	8.43	0.77	0.77	1.53	5.37	1.53	3.07	3.83
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	7.40	7.89	14.80	0.49	2.96	0.49	4.93	1.48	2.96	2.47
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	3.76	6.59	12.23	1.88	1.88	1.88	3.76	0.94	1.88	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	4.02	13.58	13.58	1.51	2.01	1.01	4.02	1.51	2.01	3.02
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	5.86	13.07	13.97	2.25	3.60	1.80	3.15	1.80	3.15	4.06
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	5.16	8.61	10.33	3.44	3.44	0.00	8.61	5.16	5.16	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	6.68	17.81	12.47	1.34	2.23	2.23	3.12	1.34	3.12	3.56
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	4.69	9.38	14.08	1.56	1.96	3.13	2.74	3.13	4.69	3.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	5.28	8.58	6.60	1.98	0.00	3.30	3.30	1.98	1.32	3.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	3.11	16.09	14.53	0.52	1.04	3.63	3.11	3.11	3.63	5.19
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	7.88	12.25	12.69	2.19	1.31	1.31	3.50	1.31	2.19	3.06
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	5.59	9.50	7.83	1.12	2.80	0.56	3.91	1.68	2.24	3.91
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	4.42	11.48	11.04	0.88	2.21	2.65	4.86	1.32	2.21	3.53
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	6.94	11.19	11.19	3.09	3.86	1.54	4.24	1.16	1.54	3.47
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	3.54	9.62	7.09	3.04	2.03	2.53	3.54	0.51	0.00	5.06
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	3.84	8.65	11.53	0.00	0.48	1.92	4.81	2.88	1.92	3.36
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	5.17	11.13	11.93	2.39	3.18	2.39	3.58	0.80	3.18	3.18
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	4.86	9.72	6.08	1.82	0.61	0.00	3.04	3.04	2.43	3.65
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	4.15	2.77	6.92	0.69	0.00	0.00	3.46	0.69	2.08	2.77
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	5.70	12.92	9.50	1.52	2.28	1.52	4.18	1.90	0.76	5.70
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	4.65	11.88	7.23	1.55	2.07	1.03	4.65	2.58	5.16	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	3.63	8.47	11.49	0.00	1.21	1.81	3.63	4.23	0.60	5.44
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	2.85	10.14	9.51	0.63	1.90	1.58	4.12	2.22	1.58	2.54
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	3.20	8.53	11.19	1.60	1.07	2.13	3.20	2.67	1.07	4.80
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	5.17	4.60	9.77	0.00	0.00	1.15	6.32	1.15	2.30	2.30
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	5.14	8.74	11.83	1.03	0.51	1.03	3.60	2.57	3.09	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	6.37	8.49	7.07	0.71	0.71	0.71	8.49	0.71	2.83	4.95
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	5.67	6.24	8.51	1.13	2.84	1.70	3.40	2.27	0.57	3.40
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	5.41	10.40	10.82	1.25	1.25	1.66	5.41	1.66	1.25	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	2.35	4.70	5.48	1.57	1.57	3.92	4.70	1.57	1.57	3.13
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	2.51	7.93	4.18	0.42	0.84	0.84	3.76	1.25	2.09	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	2.32	10.69	6.97	0.46	0.93	0.46	4.65	1.86	1.86	5.11
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	0.67	8.70	7.36	1.34	1.34	0.67	3.35	2.68	3.35	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	3.74	6.95	6.95	0.53	0.00	0.00	4.28	2.14	2.14	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	2.02	6.87	10.10	0.81	2.42	1.62	5.25	2.02	1.62	3.64
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	4.59	9.18	7.34	0.92	1.84	0.92	2.75	1.84	2.75	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	3.56	14.23	4.45	0.00	0.89	0.00	6.22	1.78	1.78	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	2.85	11.40	7.41	0.00	0.57	0.57	3.99	2.85	0.57	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	2.30	3.83	3.07	0.00	0.77	2.30	2.30	0.77	1.53	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	3.83	11.49	5.47	1.09	2.19	0.00	3.83	0.55	3.28	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	2.67	7.57	4.01	0.89	1.78	0.45	3.56	0.00	0.89	4.90
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	2.08	8.84	6.50	1.04	1.56	1.04	3.90	2.08	2.08	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	3.32	7.96	7.29	0.00	1.33	0.00	1.99	1.99	1.33	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	0.00	12.47	2.08	0.00	0.00	6.24	4.16	6.24	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	10.48	9.80	2.05	1.14	0.91	0.23	0.00	0.00	0.46	0.23
Macrophage - monocyte derived, donor2	11313-117C8	4.95	3.12	0.55	0.73	0.55	0.00	0.00	0.37	0.18	0.37
Macrophage - monocyte derived, donor3	11389-118C3	7.60	7.86	2.36	1.05	0.79	0.39	0.79	0.26	0.92	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	4.78	1.59	0.00	1.06	0.53	0.00	0.53	0.53	0.53	1.06
Mallassez-derived cells, donor2	11929-125I3	9.35	4.60	3.01	0.16	1.58	1.27	1.11	1.74	0.48	2.06
Mallassez-derived cells, donor3	11930-125I4	9.31	2.64	2.22	0.28	0.69	1.25	0.42	1.25	0.69	1.67
Mammary Epithelial Cell, donor1	11273-116H4	3.89	1.20	1.20	0.30	0.80	0.90	0.70	1.20	0.20	0.40
Mammary Epithelial Cell, donor2	11350-117G9	3.19	1.16	1.16	0.58	0.29	0.29	0.00	0.87	0.29	0.87
Mammary Epithelial Cell, donor3	11422-118F9	2.49	2.49	2.74	1.25	1.50	1.25	1.75	1.25	0.75	0.25
Mast cell - stimulated, donor1	11487-119E2	29.15	1.36	0.68	0.00	1.36	0.00	1.36	0.68	0.00	0.00
Mast cell, donor1	11563-120D6	20.44	10.27	3.57	1.41	1.19	0.97	0.11	0.87	0.32	0.65
Mast cell, donor2	11565-120D8	31.50	19.02	12.18	11.89	2.97	3.86	0.59	2.67	2.08	1.49
Mast cell, donor3	11566-120D9	31.52	19.36	12.16	6.98	2.25	4.05	0.90	2.70	3.83	0.90
Mast cell, donor4	11567-120E1	38.47	20.21	10.99	6.74	3.90	4.79	1.06	2.66	1.77	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	11.53	9.09	3.33	1.33	1.11	0.33	0.11	0.22	0.44	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	20.43	10.51	3.50	2.33	1.17	1.75	0.00	0.58	1.75	0.00
Mast cell, expanded, donor5	11939-126A4	13.54	7.11	2.75	0.80	0.57	0.69	0.23	0.46	0.23	0.23
Mast cell, expanded, donor8	11941-126A6	38.16	12.39	10.38	6.36	2.51	2.85	0.84	2.51	1.00	1.00
Melanocyte - dark, donor1	11502-119F8	6.77	2.09	1.99	0.40	0.80	0.40	0.20	1.19	0.40	0.00
Melanocyte - dark, donor2	11582-120F7	2.77	0.69	1.38	0.00	1.38	0.00	0.69	0.35	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	2.32	2.17	0.94	1.16	0.51	0.36	0.36	0.65	0.36	1.23
Melanocyte - light, donor1	11274-116H5	4.94	2.82	2.12	1.88	0.24	0.94	0.24	0.71	0.71	1.18
Melanocyte - light, donor2	11351-117H1	3.41	1.36	1.36	1.36	0.00	0.00	0.00	0.00	0.68	1.36
Melanocyte - light, donor3	11423-118G1	1.73	0.87	1.73	0.00	0.87	0.00	0.00	0.87	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	2.50	1.67	1.46	1.04	0.31	0.31	0.52	0.21	0.52	0.83
Melanocyte, donor2 (MC+2)	12739-135I3	2.42	1.08	0.81	0.54	0.27	0.54	0.27	0.81	0.54	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	5.36	2.95	2.14	2.68	1.61	2.14	1.07	1.07	1.61	3.48
Meningeal Cells, donor1	11493-119E8	8.68	2.48	1.86	0.74	0.50	0.87	0.50	0.62	0.74	0.87
Meningeal Cells, donor2	11573-120E7	6.16	2.20	0.00	0.44	0.88	0.00	0.88	0.00	0.00	0.44
Meningeal Cells, donor3	11654-122E7	4.97	0.90	0.98	1.06	0.57	1.06	0.33	1.06	0.24	0.65
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	1.71	0.57	0.86	0.00	0.00	0.29	0.00	1.14	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	2.52	2.21	0.81	0.20	0.50	0.50	0.70	1.21	0.30	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1.31	0.00	0.00	0.00	0.00	0.00	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	1.44	0.00	0.00	0.72	0.00	1.44	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	3.60	1.27	0.21	0.00	0.64	0.42	0.21	0.85	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	1.51	0.50	2.01	0.00	0.50	0.00	0.00	0.50	0.00	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	0.00	1.10	0.44	0.00	0.22	0.22	0.44	0.66	0.44	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	1.46	2.19	0.00	0.73	0.00	0.00	0.73	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	1.43	0.41	0.61	0.00	0.20	0.20	0.61	0.41	0.00	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	3.32	0.28	0.55	0.28	0.14	0.69	0.42	0.69	0.28	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	3.72	5.20	1.12	0.00	1.12	0.37	0.74	2.23	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	4.21	2.37	0.66	0.26	0.92	0.26	0.13	0.39	0.26	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	2.97	0.89	0.30	0.30	0.59	0.30	0.59	0.30	0.00	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	2.34	0.00	2.34	0.00	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	2.56	0.64	0.00	0.00	1.28	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	1.77	0.35	1.06	0.35	0.00	0.35	0.35	0.00	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	1.56	1.56	0.31	0.00	0.94	0.31	0.31	0.00	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	0.73	1.45	0.73	0.00	0.00	1.45	0.00	0.73	0.73	0.73
Mesothelial Cells, donor1	11247-116E5	5.30	2.92	0.80	0.53	0.00	0.53	0.27	0.80	0.27	1.33
Mesothelial Cells, donor2	12156-128G5	4.00	2.00	1.00	0.50	0.00	0.50	1.00	0.50	0.00	2.50
Mesothelial Cells, donor3	11402-118D7	7.30	3.69	1.81	0.58	0.58	0.94	0.79	0.58	1.16	1.88
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	12.15	8.10	1.35	0.00	1.35	0.00	2.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	6.65	5.66	0.74	0.25	0.49	0.25	0.00	0.49	0.49	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	4.71	6.48	0.59	0.59	0.59	0.00	0.29	0.00	0.88	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	3.46	0.00	3.46	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	3.72	4.65	0.93	0.31	0.62	0.00	0.00	0.00	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	4.15	5.81	0.41	0.41	0.62	0.00	1.24	0.21	0.62	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	2.32	2.32	0.00	0.00	0.00	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	8.51	7.26	0.75	0.25	0.50	0.75	0.50	0.25	0.50	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	8.38	5.59	0.93	1.86	1.40	0.47	0.47	0.00	1.40	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	5.08	2.85	0.61	1.02	0.20	0.20	0.61	0.20	0.20	1.42
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	6.34	5.15	1.58	1.19	0.79	0.00	0.40	0.00	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	0.88	0.88	1.77	0.00	1.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	5.32	2.28	1.14	0.38	0.38	0.76	0.76	0.00	0.38	2.66
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	3.18	2.97	1.49	1.06	1.06	0.21	0.21	0.21	0.42	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	4.60	0.92	0.00	0.92	0.00	0.00	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	4.77	4.17	0.60	0.60	0.00	0.00	0.00	0.00	0.00	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	1.68	3.35	1.68	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	1.25	3.26	0.00	0.00	1.25	0.00	0.25	0.00	0.00	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	3.57	4.04	0.24	0.48	0.24	0.24	0.24	0.00	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.76	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	1.38	1.38	0.23	1.38	0.46	0.00	0.00	0.00	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	4.21	3.37	0.63	0.63	0.42	0.21	0.21	0.00	0.63	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	2.65	1.83	0.00	0.00	0.00	0.00	0.20	0.20	0.00	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	3.00	1.93	0.43	0.43	0.00	0.00	0.00	0.00	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	2.67	1.78	0.22	0.44	0.44	0.00	0.00	0.00	0.89	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	2.41	0.44	0.00	0.44	0.44	0.00	0.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	2.03	1.52	0.51	0.00	0.51	0.00	0.00	0.00	0.00	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	0.00	0.00	0.00	1.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	1.63	2.99	0.00	0.00	0.27	0.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	2.06	1.76	0.88	0.59	0.00	0.00	0.29	0.00	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	1.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	0.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	1.20	2.40	0.00	0.40	0.40	0.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	1.37	1.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	0.00	0.00	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	1.31	1.31	0.00	0.00	0.44	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	0.00	1.10	0.00	0.00	0.00	0.00	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	1.28	1.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	0.99	0.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	0.00	0.70	0.00	0.00	0.70	0.00	0.00	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	0.00	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	1.71	2.39	0.34	0.00	0.00	0.00	0.00	0.00	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	1.75	1.75	0.00	0.00	0.88	0.00	0.44	0.00	0.00	1.75
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	4.97	2.13	0.00	0.71	0.36	0.36	0.36	0.00	0.36	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	1.68	1.12	0.00	0.28	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	2.08	2.08	0.00	0.42	0.42	0.00	0.83	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	6.99	2.33	0.00	0.00	0.00	0.00	0.00	0.00	0.58	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	3.02	3.32	0.30	0.30	0.60	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	6.26	2.50	0.42	0.42	0.42	0.00	0.00	0.00	0.00	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	4.62	0.92	0.00	0.92	0.00	0.92	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	2.85	3.41	0.57	0.57	0.00	0.00	0.57	0.00	0.57	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	7.60	2.07	0.41	0.41	0.97	0.41	0.41	0.14	0.00	1.11
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	2.85	1.81	0.52	0.00	0.26	0.00	0.00	0.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	5.15	5.15	0.86	0.43	0.00	0.00	0.43	0.00	0.43	1.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.81	3.18	0.00	0.00	1.27	0.00	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	4.27	2.67	0.00	0.00	0.27	0.00	0.53	0.00	0.27	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	6.29	4.49	0.60	0.90	0.90	0.00	0.30	0.00	0.30	1.20
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	8.19	3.11	0.99	0.42	1.13	0.28	0.28	0.57	0.42	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	2.55	2.23	0.32	0.00	1.59	0.00	0.00	0.64	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	7.08	3.54	0.22	0.00	0.44	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	7.96	3.41	0.76	0.00	1.52	0.38	0.00	0.00	0.38	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	3.41	2.27	0.28	0.00	0.28	0.00	0.00	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	7.87	2.46	0.74	0.25	0.49	0.00	0.74	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	12.38	5.21	1.30	0.65	0.65	0.00	0.00	1.30	1.30	1.96
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	9.11	4.41	0.29	0.59	1.18	0.00	0.29	0.00	0.00	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	9.51	6.34	0.29	0.58	1.44	0.29	0.29	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	18.13	14.84	1.24	1.24	1.65	1.65	0.41	0.41	0.41	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	8.64	7.15	1.79	0.00	0.60	0.30	0.00	0.00	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	3.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	0.00	0.00	0.00	0.00	1.78	0.00	0.00	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	6.57	4.27	0.99	0.66	0.33	0.66	0.33	0.66	0.99	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	4.21	1.05	1.05	0.00	0.00	0.00	0.00	2.10	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	3.76	4.15	2.17	1.19	0.59	0.00	0.20	0.00	0.40	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	6.52	5.59	0.93	0.93	0.93	0.00	0.93	0.00	1.86	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	7.89	6.01	2.25	0.38	1.13	1.13	0.38	0.00	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	1.86	2.13	1.33	0.80	0.53	0.00	0.00	0.00	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	2.71	5.09	0.45	0.45	0.11	0.11	0.00	0.11	0.00	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	2.95	2.21	0.74	0.00	0.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	6.23	3.30	2.56	0.37	0.73	0.73	0.00	0.00	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	4.67	3.11	1.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	2.14	1.07	0.53	0.53	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	2.02	5.05	0.00	2.02	0.00	0.00	0.00	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	1.26	0.84	0.00	0.00	0.42	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	2.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	11.42	5.71	0.00	17.13	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	0.00	3.26	0.00	0.00	0.00	0.00	0.00	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	0.00	4.75	0.00	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	12.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	2.80	1.51	0.22	0.00	0.65	0.43	0.00	0.43	0.00	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	2.61	4.18	1.05	0.00	0.52	0.52	0.52	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	1.33	0.67	0.67	0.00	0.00	0.67	0.00	0.67	0.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	0.83	0.42	0.83	0.00	0.00	0.00	0.83	0.00	0.00	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	2.47	0.38	1.71	0.57	0.57	1.52	0.00	0.57	0.38	0.95
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	6.38	0.00	4.79	3.19	1.60	1.60	0.00	1.60	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	0.00	0.00	0.00	0.68	0.00	0.68	0.00	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	9.19	3.68	1.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	1.26	0.42	0.84	0.42	0.00	0.00	0.00	0.00	0.42	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	0.23	0.23	0.23	0.46	0.46	0.23	0.00	0.23	0.23	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	3.78	1.62	2.16	0.54	0.54	0.27	0.54	0.27	0.27	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	3.15	1.47	1.68	0.21	0.42	0.84	0.84	1.05	0.84	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	22.27	0.00	0.00	0.00	11.13	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	0.99	0.50	0.99	0.00	0.99	0.00	0.00	0.00	0.00	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	2.44	1.08	1.35	0.00	0.27	0.00	0.00	0.81	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	2.04	0.91	0.45	0.45	0.00	0.68	0.45	0.00	0.00	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	1.31	0.65	1.47	0.00	1.47	0.82	0.65	0.49	0.65	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	3.28	1.64	0.91	0.18	0.73	1.09	0.55	0.73	0.36	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	1.59	0.53	1.59	1.06	0.00	1.06	0.53	0.53	1.06	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	2.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.80	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	5.91	0.98	2.30	0.66	0.33	0.66	0.98	0.00	0.66	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	1.79	0.98	0.81	0.00	0.16	0.49	0.33	0.33	0.81	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	4.94	3.17	3.35	0.71	0.18	1.06	0.35	1.41	1.06	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	1.41	2.11	1.41	0.00	0.00	0.00	0.00	2.11	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	0.00	0.46	0.46	0.92	0.46	0.00	0.92	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	1.61	1.61	0.96	0.00	0.00	0.64	0.00	0.64	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	3.10	2.07	1.72	0.69	0.00	1.38	0.69	0.34	0.34	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	7.59	12.64	7.59	0.00	0.00	0.00	2.53	0.00	7.59	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	2.90	1.11	2.90	0.89	0.00	1.56	0.67	0.45	0.45	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	0.85	1.69	0.00	0.00	0.42	0.85	0.42	0.00	0.00	1.69
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	1.66	0.24	1.90	0.71	0.00	0.71	0.24	0.47	0.71	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	0.86	1.72	0.43	1.29	0.00	0.00	0.00	0.00	0.00	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	9.03	0.00	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	1.33	1.33	0.67	0.33	0.67	0.67	0.67	1.00	0.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	4.51	2.71	1.35	0.90	0.45	1.35	0.45	1.80	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	0.79	0.00	0.40	0.40	0.00	0.40	0.00	0.40	0.79	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	0.93	0.00	0.93	0.00	0.00	0.93	0.00	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	1.14	1.51	1.14	0.38	0.00	0.38	0.00	0.00	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	2.61	3.26	0.00	0.33	0.33	0.98	0.65	0.98	0.00	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	5.23	0.44	3.05	0.44	1.31	0.87	0.00	0.44	0.44	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	3.17	3.62	1.36	0.00	0.90	0.00	0.45	0.90	2.71	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	2.65	0.88	2.65	0.00	0.00	1.76	0.88	1.76	0.88	2.65
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	0.66	0.00	0.00	0.00	0.00	0.00	1.33	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	2.48	0.50	0.99	0.00	0.99	0.99	0.00	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	2.30	1.53	1.53	0.00	0.38	0.77	0.38	0.77	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	3.93	0.91	2.72	0.60	1.21	0.91	0.30	0.60	0.30	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	2.87	1.33	1.99	0.88	0.22	0.88	0.44	0.66	0.88	1.33
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	0.00	0.68	0.68	0.00	1.36	1.36	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	0.00	0.00	5.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	3.66	0.61	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	0.94	0.94	0.63	0.00	0.94	1.57	0.31	0.31	0.63	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	3.93	1.82	0.91	0.61	0.61	0.91	0.00	0.30	0.61	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	0.79	0.79	1.58	0.00	0.00	0.79	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	2.27	3.40	1.13	2.27	4.53	0.00	1.13	1.13	3.40	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	1.24	0.62	0.99	0.12	0.00	0.25	0.00	0.00	0.12	0.37
Myoblast, donor2	11322-117D8	1.73	1.34	0.38	0.38	0.96	0.58	0.19	0.38	0.77	0.00
Myoblast, donor3	11398-118D3	2.69	0.67	0.84	0.50	0.34	0.67	0.34	0.67	0.17	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	10.51	3.36	5.40	9.63	8.03	3.79	0.73	2.33	2.19	3.36
Natural Killer Cells, donor1	11230-116C6	54.12	11.07	24.60	21.83	8.92	11.07	1.23	8.00	2.15	4.00
Natural Killer Cells, donor2	11311-117C6	51.57	10.25	17.79	19.60	9.35	14.78	0.60	6.63	0.90	2.41
Natural Killer Cells, donor3	11387-118C1	56.32	13.80	20.43	20.43	9.20	11.41	0.18	6.07	2.02	2.76
Neural stem cells, donor1	11275-116H6	17.06	6.90	10.53	1.45	1.45	4.72	6.53	7.26	1.09	2.18
Neural stem cells, donor2	11352-117H2	30.81	1.93	21.18	0.00	9.63	13.48	9.63	3.85	1.93	5.78
Neurons, donor1	11494-119E9	3.41	1.14	13.65	0.00	1.14	3.41	2.28	5.69	1.14	3.41
Neurons, donor2	11574-120E8	5.72	6.38	17.83	0.88	1.76	4.62	0.66	3.96	1.54	0.66
Neurons, donor3	11655-122E8	1.64	0.82	4.11	1.64	3.29	4.11	2.47	1.64	0.82	1.64
Neutrophils, donor1	11233-116C9	186.53	80.74	9.28	27.84	33.41	0.93	0.93	0.93	0.00	1.86
Neutrophils, donor2	11314-117C9	133.35	115.96	14.49	5.80	31.89	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	209.52	119.11	13.44	29.93	62.31	0.61	0.61	0.61	0.61	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	3.56	2.97	3.56	1.07	1.42	1.42	1.78	0.83	0.59	2.14
Nucleus Pulposus Cell, donor2	11409-118E5	2.93	2.28	1.30	0.65	0.98	1.30	0.65	0.00	0.65	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	3.01	1.00	0.60	0.20	0.20	0.40	0.20	0.60	0.60	0.80
Olfactory epithelial cells, donor1	11933-125I7	2.34	0.96	0.55	0.41	0.14	0.28	0.41	0.41	0.28	0.28
Olfactory epithelial cells, donor2	11934-125I8	1.16	0.58	0.00	0.14	0.29	0.14	0.29	0.29	0.00	0.43
Olfactory epithelial cells, donor3	11935-125I9	2.27	1.59	0.34	0.00	0.91	0.11	0.34	0.23	0.23	0.23
Olfactory epithelial cells, donor4	11936-126A1	3.70	1.85	0.78	0.39	0.49	0.49	0.49	0.39	0.39	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	9.63	4.21	1.81	1.81	1.20	2.41	3.61	1.20	1.20	1.20
Osteoblast - differentiated, donor1	11276-116H7	1.28	2.13	1.49	0.00	0.64	0.85	0.21	0.64	0.21	0.43
Osteoblast - differentiated, donor2	11353-117H3	1.14	2.29	2.29	0.00	1.14	0.00	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	1.24	3.10	0.00	0.00	1.24	0.62	1.24	0.00	0.62	0.00
Osteoblast, donor1	11277-116H8	1.95	2.15	2.35	0.78	0.20	1.17	1.17	0.39	0.59	0.39
Osteoblast, donor2	11354-117H4	1.40	2.11	0.00	0.00	0.00	0.00	0.00	1.40	0.70	0.00
Osteoblast, donor3	11426-118G4	2.67	0.89	0.53	0.36	0.71	1.24	0.53	0.53	0.18	0.53
Pancreatic stromal cells, donor1	11249-116E7	1.68	1.26	0.84	0.34	0.08	0.42	0.59	0.93	0.34	0.08
Pericytes, donor1	11491-119E6	7.12	2.23	3.45	1.45	2.00	0.56	0.78	1.11	0.45	1.00
Pericytes, donor2	11571-120E5	9.28	1.58	3.17	1.36	0.68	1.58	0.45	0.68	0.68	2.26
Pericytes, donor3	11652-122E5	3.26	1.02	1.22	0.00	0.61	0.00	0.41	0.81	0.20	0.00
Perineurial Cells, donor1	11499-119F5	4.41	0.68	2.37	0.57	0.57	1.02	0.57	0.57	0.34	0.57
Perineurial Cells, donor2	11579-120F4	1.84	1.29	1.01	0.46	1.10	0.37	0.28	0.18	0.37	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	35.38	37.93	21.36	24.22	7.01	6.69	1.59	4.78	3.51	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	29.14	19.34	8.08	12.73	7.10	2.94	0.00	1.96	1.22	1.96
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	34.04	17.99	18.12	15.92	6.60	5.82	0.78	4.27	2.72	2.46
Placental Epithelial Cells, donor1	11278-116H9	1.91	3.35	0.00	0.00	0.48	0.00	1.20	0.72	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	8.87	5.54	0.00	0.00	1.11	0.00	0.00	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	2.75	2.94	1.57	0.00	0.59	1.18	2.94	0.59	0.59	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	2.85	1.27	0.63	0.00	0.32	0.32	0.32	0.32	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	1.88	1.88	0.19	0.00	0.38	0.19	0.38	0.19	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	2.61	1.70	0.26	0.00	0.00	0.13	0.13	0.13	0.00	0.39
Preadipocyte - breast, donor2	11328-117E5	1.58	1.13	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.23
Preadipocyte - omental, donor1	11468-119C1	2.77	1.39	0.64	0.00	0.43	0.21	0.11	0.21	0.11	0.32
Preadipocyte - omental, donor2	11329-117E6	2.62	2.18	1.31	0.44	0.44	0.44	0.00	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	4.87	1.43	0.57	0.14	0.43	0.14	0.14	0.00	0.14	0.29
Preadipocyte - perirenal, donor1	11469-119C2	1.97	0.00	0.98	0.00	0.00	0.98	0.00	0.00	0.00	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	2.76	1.84	0.61	0.00	0.31	0.61	0.31	0.00	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	0.89	1.06	0.53	0.35	0.00	0.18	0.35	0.00	0.53	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	0.68	1.02	0.51	0.34	0.51	0.34	0.34	0.00	0.00	0.34
Preadipocyte - visceral, donor1	11280-116I2	2.14	1.02	0.65	0.09	0.28	0.19	0.28	0.56	0.37	0.75
Preadipocyte - visceral, donor2	11357-117H7	1.84	1.84	0.00	0.00	0.92	0.46	0.46	0.00	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	0.63	0.94	0.31	0.00	0.10	0.10	0.00	0.00	0.00	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	8.30	5.88	8.00	1.21	3.62	4.53	10.41	4.22	1.06	2.56
Prostate Epithelial Cells, donor2	11331-117E8	7.04	4.33	3.79	0.95	1.08	1.08	1.76	2.17	0.81	1.90
Prostate Epithelial Cells, donor3	11404-118D9	4.84	10.04	2.63	0.55	2.51	2.63	0.80	2.20	0.80	1.16
Prostate Stromal Cells, donor1	11254-116F3	1.14	1.25	0.80	0.00	0.34	0.91	0.23	0.57	0.46	0.11
Prostate Stromal Cells, donor2	11332-117E9	5.02	1.43	0.90	0.18	1.08	0.36	0.54	1.08	0.36	0.72
Prostate Stromal Cells, donor3	11405-118E1	3.44	1.46	0.73	0.00	0.42	0.42	0.52	0.31	0.21	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	14.23	8.76	5.84	2.19	2.55	0.36	2.92	3.28	2.55	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	7.97	2.29	3.40	0.55	1.25	1.32	0.90	1.87	1.39	0.55
Renal Epithelial Cells, donor1	11517-119H5	10.14	3.55	5.07	2.54	2.54	1.52	3.55	3.55	1.52	2.03
Renal Epithelial Cells, donor2	11597-120H4	9.25	4.98	3.56	2.13	0.71	2.13	1.42	0.71	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	10.59	3.92	3.71	1.38	1.69	1.16	0.85	1.69	1.27	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	8.17	4.77	1.36	0.00	0.00	0.00	1.36	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	3.64	2.83	0.27	0.81	0.40	0.27	0.40	0.13	0.67	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	7.33	2.66	1.78	0.89	1.33	1.11	0.89	0.44	1.11	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	29.94	9.98	5.99	3.33	2.00	2.00	1.33	0.67	2.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	6.38	1.76	1.98	1.10	0.88	0.66	1.32	1.76	0.66	0.22
Renal Mesangial Cells, donor2	11598-120H5	5.02	2.51	1.88	0.63	1.25	1.88	1.25	0.63	0.63	1.88
Renal Mesangial Cells, donor3	11679-122H5	6.10	2.77	1.39	1.11	2.22	1.11	1.11	0.55	0.83	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	6.98	4.03	3.22	0.54	1.07	1.61	2.42	1.88	1.61	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	5.90	2.11	1.69	0.00	1.69	1.27	0.84	0.00	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	5.98	2.89	5.01	1.16	1.16	1.74	2.31	1.93	0.77	0.96
Retinal Pigment Epithelial Cells, donor0	11215-116A9	3.11	1.56	5.70	0.78	0.52	1.30	2.33	1.81	0.26	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	3.70	6.54	10.23	3.13	1.42	2.84	4.26	1.99	3.13	1.42
Retinal Pigment Epithelial Cells, donor2	11608-120I6	1.03	0.00	7.20	2.06	0.00	1.03	2.06	1.03	1.03	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	8.03	2.01	6.02	1.00	2.01	1.51	3.76	2.51	1.76	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	12.43	14.57	3.61	1.20	4.54	0.94	0.80	1.34	0.94	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	4.47	3.57	5.36	0.00	0.00	2.68	5.36	0.89	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	8.81	3.85	6.60	2.20	2.20	3.30	3.30	0.55	1.10	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	8.12	4.06	6.96	1.16	0.00	4.06	2.32	4.64	0.58	2.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	7.93	5.20	4.42	1.17	0.78	2.34	3.12	2.21	1.04	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	7.75	3.57	4.57	1.29	1.19	3.38	2.38	2.98	1.09	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	7.58	4.68	5.35	0.67	1.45	3.57	2.90	3.01	1.34	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	8.19	6.70	5.21	0.99	1.49	2.85	1.86	4.34	1.24	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	7.81	3.26	5.36	1.63	0.93	1.98	1.98	2.45	1.17	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	11.09	7.86	4.62	1.39	0.69	3.24	2.54	3.47	1.39	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	6.71	4.79	3.01	1.10	0.96	0.68	3.29	1.92	1.92	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	8.47	2.42	3.18	1.36	0.91	3.48	2.87	2.12	1.51	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	10.03	3.23	6.09	1.08	1.25	3.05	1.97	2.51	1.08	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	8.18	3.44	4.45	0.43	0.72	1.43	1.72	2.30	1.43	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	9.44	4.08	3.65	0.75	0.43	2.47	2.04	3.22	1.82	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	8.63	4.65	5.75	0.00	0.89	2.43	2.43	3.10	1.99	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	9.75	3.44	5.16	1.15	0.76	1.91	3.25	1.53	1.34	2.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	7.36	4.84	4.38	1.30	1.12	2.33	2.98	3.26	1.30	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	11.27	6.01	8.27	1.88	1.50	5.26	3.38	5.26	2.07	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	10.35	3.18	3.18	1.06	0.53	2.26	3.98	2.39	1.59	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	8.18	3.50	5.55	1.27	1.56	3.80	3.02	3.60	1.65	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	8.59	3.82	8.78	2.67	0.57	3.44	2.86	3.44	1.53	2.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	7.80	3.63	3.95	0.96	0.21	1.50	2.67	1.50	0.96	2.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	9.81	2.80	4.77	1.12	0.84	3.08	2.52	2.24	2.24	2.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	10.60	3.59	4.61	1.37	0.85	3.42	3.42	3.93	1.37	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	9.66	3.83	3.10	1.09	1.28	1.09	2.01	1.28	2.19	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	8.83	3.80	5.03	1.59	1.59	4.17	3.31	2.45	1.84	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	8.19	4.30	6.85	0.94	0.81	3.22	2.01	3.63	1.21	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	5.90	3.30	1.65	0.94	0.47	1.18	2.36	1.65	0.47	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	9.33	3.97	5.16	0.60	1.59	3.37	3.77	1.98	1.79	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	7.02	3.98	6.55	1.17	1.40	3.74	3.27	1.64	1.40	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	5.39	3.53	1.45	0.62	0.62	1.45	1.24	1.24	0.62	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	8.41	2.65	3.10	0.66	0.22	3.98	2.43	2.88	1.55	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	7.94	5.43	3.34	1.04	1.88	2.72	3.97	3.13	1.67	1.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	5.38	4.17	2.96	1.35	0.27	0.94	1.08	1.62	1.48	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	9.20	2.72	5.28	0.85	0.68	2.72	2.38	2.21	1.53	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	7.52	3.47	4.05	0.96	0.58	3.08	1.93	1.93	1.35	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	6.02	6.19	2.41	0.34	0.00	1.38	1.72	0.69	1.20	1.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	7.00	2.33	2.88	0.27	0.41	1.51	2.33	0.82	1.37	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	8.21	4.10	3.61	0.16	0.49	1.97	1.31	2.30	1.15	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	7.33	4.43	3.58	0.17	0.51	1.87	1.70	1.19	1.87	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	9.32	3.99	4.73	2.52	0.44	2.66	2.37	2.07	1.63	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	13.86	7.20	6.40	1.33	1.33	4.00	2.67	3.47	2.93	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	9.96	7.05	5.67	2.49	1.24	2.90	3.46	3.73	2.21	1.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	9.52	6.43	5.48	1.43	1.67	2.14	4.52	2.14	1.19	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	16.12	14.51	9.88	1.21	1.61	9.07	2.62	5.24	4.03	2.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	9.04	6.97	4.33	1.22	0.94	3.86	1.70	3.11	2.83	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	13.28	6.29	6.29	1.75	1.40	3.14	2.79	4.54	2.45	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	11.18	5.14	6.04	0.60	1.21	2.72	4.23	2.72	1.81	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	7.22	6.98	2.94	0.61	0.61	1.96	1.47	2.33	0.73	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	18.78	9.02	12.81	2.91	5.53	4.95	3.93	9.17	2.62	2.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	5.48	5.48	3.65	0.00	0.61	3.65	1.83	2.43	1.22	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	5.73	4.52	3.32	0.60	1.21	0.60	2.11	1.51	0.90	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	10.86	8.37	6.33	2.04	1.81	3.62	2.26	4.30	1.58	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	11.08	6.59	5.69	1.20	2.10	5.39	2.40	6.29	1.50	2.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	10.51	6.61	6.02	1.53	2.36	2.48	2.48	4.25	1.53	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	11.95	7.04	5.76	1.28	1.92	2.99	3.42	3.84	1.28	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	6.01	7.21	10.22	0.60	1.80	5.41	3.61	3.61	0.00	1.80
Schwann Cells, donor1	11498-119F4	3.57	1.13	0.56	0.19	0.19	0.94	1.13	0.75	0.56	0.56
Schwann Cells, donor2	11578-120F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	2.63	0.66	0.88	0.22	0.44	0.66	0.00	0.00	0.44	0.22
Sebocyte, donor1	11220-116B5	41.08	16.43	16.98	3.29	2.19	9.31	7.12	4.38	4.38	9.31
Sebocyte, donor2	11301-117B5	11.95	4.60	5.97	0.00	0.92	3.68	4.14	1.84	1.84	2.76
Sebocyte, donor3	11378-118B1	8.45	5.98	3.71	0.62	2.06	1.65	0.62	0.21	1.44	0.62
Sertoli Cells, donor1	11255-116F4	1.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	0.00	0.00	0.00	0.00	2.82	0.00	0.00	5.65	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	6.77	1.67	2.02	1.06	1.41	1.76	2.29	1.50	1.58	0.79
Skeletal Muscle Cells, donor2	11358-117H8	3.61	3.61	2.89	0.72	1.45	0.00	1.45	0.00	1.45	0.72
Skeletal Muscle Cells, donor3	11430-118G8	5.85	2.51	2.51	2.51	0.84	0.00	1.67	2.51	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	1.57	0.47	0.16	0.16	0.00	0.16	0.63	0.16	0.16	0.16
Skeletal Muscle Cells, donor5	11455-119A6	1.34	0.30	0.89	0.30	0.15	0.00	0.74	0.45	0.59	0.74
Skeletal Muscle Cells, donor6	11459-119B1	1.54	0.46	1.39	0.92	0.15	0.62	1.08	0.46	0.92	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	3.78	1.13	1.39	0.50	0.76	0.76	0.38	1.13	0.76	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	3.42	1.00	1.85	0.14	0.29	0.43	1.14	0.14	0.71	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	2.28	0.69	2.38	0.60	0.30	0.60	0.89	0.50	0.50	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	3.29	1.60	2.61	0.17	0.76	1.35	1.18	1.77	0.76	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	5.79	0.72	1.45	0.72	2.90	2.90	1.45	0.72	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	1.79	0.96	1.24	0.00	0.69	0.41	0.96	0.28	0.28	1.51
Skin - palm, donor1	10286-104F7	5.37	2.69	0.00	5.37	2.69	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	6.63	3.17	3.03	0.86	0.72	0.86	0.29	1.59	1.15	0.72
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	17.99	17.18	12.27	0.00	3.27	1.64	6.54	5.73	1.64	6.54
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	6.88	3.76	4.02	1.69	0.78	0.65	0.78	1.43	1.43	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	8.20	2.78	2.22	0.14	1.39	1.39	1.67	1.81	0.70	1.95
Small Airway Epithelial Cells, donor2	11334-117F2	10.41	4.78	4.78	1.69	2.11	1.83	1.83	2.25	0.56	3.24
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	22.41	12.26	14.80	2.96	3.81	4.44	3.59	3.81	3.81	2.33
Small Airway Epithelial Cells, donor3	11406-118E2	11.84	7.12	4.20	0.60	4.57	3.22	2.17	3.15	0.90	2.40
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	1.54	0.93	0.62	0.00	0.00	0.31	0.00	0.31	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	4.45	1.33	0.44	0.00	0.44	0.00	0.44	0.67	0.00	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	1.76	1.76	1.18	0.00	0.59	0.00	0.00	0.59	1.18	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	3.54	1.10	0.66	0.00	0.66	0.66	0.44	0.00	1.55	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	2.36	0.79	0.79	0.79	1.18	0.79	1.18	0.79	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	5.41	2.32	1.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	7.01	7.01	2.00	0.00	0.00	0.00	0.00	2.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	3.06	1.46	1.06	0.27	0.53	0.53	0.40	0.13	0.13	0.93
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	2.22	0.89	0.44	0.00	0.00	0.00	0.44	0.00	0.22	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	1.41	0.64	0.26	0.00	0.13	0.13	0.13	0.00	0.00	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	2.28	0.00	0.33	0.65	0.65	0.65	0.00	0.00	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	2.36	0.59	0.30	0.00	0.00	0.30	0.30	0.00	0.00	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	1.99	0.43	0.43	0.00	0.43	0.14	0.00	0.28	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2.93	0.98	0.65	0.49	0.16	0.98	1.30	1.14	0.16	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	2.74	0.61	0.00	0.00	0.00	0.30	0.30	0.30	0.00	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	2.78	1.52	2.78	0.00	0.51	0.25	0.00	0.25	0.25	1.52
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.77	2.38	2.38	0.48	0.48	0.00	0.48	0.48	0.00	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	1.33	0.88	0.59	0.00	0.00	0.44	0.15	0.00	0.00	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	1.08	0.86	0.43	0.22	0.43	0.00	0.43	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	2.20	1.05	0.63	0.00	0.21	0.21	0.42	0.31	0.31	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	3.09	1.24	1.39	0.15	0.62	0.62	1.39	0.62	0.15	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	0.00	2.16	0.00	0.00	1.08	1.08	1.08	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	1.79	1.79	0.90	0.00	0.60	0.00	0.00	0.30	0.60	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	4.78	2.05	1.71	0.68	0.68	0.68	1.71	0.68	0.68	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	3.53	1.18	1.41	0.31	0.79	0.39	0.39	0.94	0.47	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	4.03	1.41	0.60	0.00	0.50	0.30	0.00	0.20	0.20	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	7.51	1.37	0.91	0.00	0.91	0.00	0.91	0.00	0.46	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	2.42	1.21	0.60	0.00	0.60	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	1.85	2.12	1.59	0.53	0.26	1.85	0.53	1.59	0.53	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	1.86	1.46	0.13	0.00	0.27	0.13	0.00	0.27	0.27	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	2.13	1.13	0.75	0.13	0.38	0.50	0.13	0.25	0.25	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	1.01	1.01	0.00	0.00	0.00	0.51	0.51	0.25	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	2.56	0.90	0.30	0.15	0.45	0.45	0.30	0.15	0.15	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	3.00	0.75	0.00	0.00	0.00	1.50	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	2.58	0.00	1.29	0.00	2.58	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	3.72	4.65	3.72	0.93	0.93	0.93	0.93	0.93	0.47	1.86
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	3.53	1.51	0.00	0.00	0.50	0.50	0.00	1.01	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	2.19	2.19	1.25	0.00	1.25	0.63	0.00	0.00	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.06	1.47	0.00	0.29	0.59	0.29	0.00	0.00	0.59	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	1.75	0.92	0.83	0.00	0.33	0.17	1.17	0.33	0.42	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	1.87	1.40	0.47	0.47	0.93	0.47	0.47	0.00	0.47	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	2.88	1.30	1.58	0.14	0.43	0.72	0.29	0.29	0.86	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	4.08	3.06	1.53	1.53	0.25	0.76	2.04	0.51	1.02	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	2.82	0.56	0.19	0.19	0.38	0.75	0.00	0.56	0.38	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	3.07	1.40	0.56	0.42	0.56	0.56	0.42	0.28	0.56	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	1.76	0.84	0.50	0.08	0.17	0.25	0.34	0.50	0.08	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	7.14	2.38	0.95	0.00	1.43	0.00	0.00	1.43	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	6.61	2.69	1.22	0.73	1.71	0.98	0.24	0.24	0.24	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	0.88	0.66	0.22	0.00	0.22	0.00	0.22	0.44	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	1.76	0.29	0.29	0.00	0.29	0.00	0.29	0.29	0.00	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	2.14	2.92	1.17	0.00	0.78	0.00	0.39	0.39	0.19	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	0.79	0.79	0.00	0.00	0.26	0.00	0.00	0.26	0.00	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	1.49	0.00	0.37	0.37	0.00	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	3.23	1.44	0.36	0.00	0.36	0.00	0.00	0.36	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	1.99	1.14	0.00	0.00	0.28	0.00	0.00	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	1.58	1.58	0.79	0.00	0.00	0.39	0.00	0.00	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	0.76	1.02	0.51	0.51	0.51	0.25	0.25	0.00	0.25	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	2.40	2.40	0.40	0.00	0.00	1.60	0.00	0.40	0.80	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	0.84	0.00	0.42	0.00	0.00	0.00	0.84	0.00	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	2.75	0.92	0.00	0.00	0.46	0.00	0.00	0.00	0.46	0.46
Synoviocyte, donor1	11291-117A4	2.19	1.51	0.67	0.17	0.34	0.17	0.00	0.34	0.67	0.34
Synoviocyte, donor2	11368-117I9	2.85	1.68	0.67	0.00	0.50	0.50	0.00	0.34	0.50	0.50
Synoviocyte, donor3	11440-118H9	3.35	2.01	1.12	0.00	0.67	0.67	0.22	0.00	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	2.50	1.79	2.50	0.36	0.71	0.36	1.07	0.36	0.71	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	0.00	0.00	0.00	0.00	3.96	0.00	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	3.01	2.08	1.62	1.39	1.62	0.00	0.69	0.93	0.69	1.39
Tracheal Epithelial Cells, donor1	11292-117A5	8.39	3.23	3.51	0.93	1.51	1.43	1.43	2.29	1.00	0.86
Tracheal Epithelial Cells, donor2	11369-118A1	7.73	3.48	2.71	0.39	1.16	1.16	1.55	1.55	1.55	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	6.30	4.01	1.15	0.00	1.15	2.86	0.57	1.72	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	11.56	15.13	2.95	0.62	5.66	0.74	0.74	1.72	0.49	0.62
Urethra, donor2	10319-105A4	12.59	10.79	10.79	0.00	5.40	3.60	1.80	5.40	0.00	0.00
Urothelial Cells, donor1	11520-119H8	17.00	3.98	5.05	0.53	0.80	1.59	1.86	2.13	1.06	1.86
Urothelial Cells, donor2	11600-120H7	10.82	2.80	2.40	0.40	1.20	0.80	2.40	0.80	0.80	0.00
Urothelial Cells, donor3	11681-122H7	10.31	5.27	4.58	0.46	0.69	0.92	2.29	1.60	0.46	0.92
Urothelial cells, donor0	11216-116B1	14.27	7.36	4.68	0.67	2.45	0.67	0.67	1.78	1.78	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	43.60	62.28	13.35	15.13	13.35	0.89	1.78	3.56	2.67	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	52.90	75.77	12.87	15.73	8.58	1.43	0.00	0.00	4.29	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	42.44	43.12	21.22	15.06	16.43	4.11	0.00	6.16	2.74	2.74
Whole blood (ribopure), donor090325, donation1	12176-128I7	34.09	48.21	19.97	17.56	6.54	5.17	0.69	2.41	4.48	2.75
Whole blood (ribopure), donor090325, donation2	12177-128I8	37.19	34.28	15.11	18.01	7.55	2.91	0.58	3.49	3.49	1.74
Whole blood (ribopure), donor090612, donation1	12182-129A4	49.98	87.46	13.54	15.62	15.62	2.08	0.00	3.12	3.12	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	50.48	66.08	13.77	11.93	11.93	2.75	0.00	2.75	1.84	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	21.91	38.34	17.35	21.91	7.30	6.39	0.91	3.65	2.74	1.83
Wilms' tumor cell line:G-401	10809-111A8	7.28	2.71	2.96	1.11	0.49	1.73	5.67	1.60	1.11	0.49
Wilms' tumor cell line:HFWT	10597-108E3	8.80	1.76	7.92	2.64	9.68	2.64	14.08	2.64	0.88	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	12.85	6.70	5.31	0.28	5.87	3.35	2.23	4.47	0.00	2.51
achilles tendon, donor2	10292-104G4	10.33	4.13	2.07	0.00	0.00	0.00	2.07	0.00	4.13	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	2.55	7.65	7.39	3.82	2.04	0.76	1.27	1.78	1.78	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	3.48	5.80	8.13	12.31	2.09	2.09	2.32	1.39	3.25	3.95
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	7.48	5.94	20.89	8.19	2.14	5.10	1.78	4.75	0.71	1.31
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	5.44	6.53	22.31	15.51	2.99	5.71	3.27	1.90	4.63	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	6.46	4.50	8.15	5.62	1.41	1.69	1.12	2.25	0.56	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	4.44	2.54	6.77	5.50	0.63	0.63	1.48	1.27	1.90	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	17.69	2.45	11.16	8.17	6.81	4.36	0.82	2.72	0.82	3.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	10.58	3.08	10.13	6.61	2.20	2.20	7.93	0.88	1.76	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	11.03	2.04	17.15	12.66	1.23	4.08	2.04	3.27	4.90	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	11.26	3.49	14.76	9.71	2.33	3.49	3.11	0.78	3.11	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	7.91	11.04	23.74	13.62	1.84	4.78	5.89	2.21	5.89	5.70
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	7.80	7.80	3.90	0.00	3.90	11.70	0.00	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	12.78	4.65	8.37	11.39	1.86	2.09	1.63	3.25	1.63	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	12.17	8.28	18.90	9.84	2.59	4.14	6.21	3.37	5.44	3.88
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	9.35	7.31	15.49	10.23	2.92	3.21	6.72	2.05	7.01	2.92
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	7.44	6.04	9.30	5.58	3.25	0.93	1.39	2.32	2.79	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	6.17	4.11	9.46	9.05	0.82	2.47	3.29	1.23	4.94	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	6.14	1.23	4.91	6.14	1.23	3.07	1.53	3.07	4.60	2.15
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	8.53	2.56	7.68	5.12	0.00	2.99	2.13	0.43	4.27	2.13
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	7.58	7.58	12.74	4.85	0.91	2.73	5.46	3.03	3.03	3.03
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	10.83	5.78	9.39	6.50	0.96	4.09	3.37	3.85	2.17	3.13
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	2.23	5.57	6.68	6.68	2.00	2.00	2.67	1.78	4.23	0.89
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	4.34	5.00	3.00	1.00	0.67	1.00	3.00	1.33	2.33	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	1.86	3.72	1.86	1.86	1.86	1.86	16.72	1.86	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	12.43	9.79	12.05	10.92	1.88	5.27	1.88	1.51	4.14	1.88
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	23.55	10.90	12.21	20.93	1.74	4.80	9.59	3.93	3.93	2.18
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	11.25	7.50	18.74	18.74	3.75	9.37	9.37	5.62	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	3.77	8.01	3.53	2.59	0.71	2.83	0.24	0.94	2.59	0.00
adipose tissue, adult, pool1	10010-101C1	8.38	11.79	1.86	0.31	2.64	1.09	0.16	0.47	0.16	0.31
adipose, donor1	10184-103D4	17.01	8.21	18.18	1.76	4.69	7.04	5.28	3.52	0.00	0.59
adipose, donor2	10185-103D5	10.54	3.24	14.60	1.22	3.65	6.08	3.65	2.03	0.00	1.62
adipose, donor3	10186-103D6	11.16	3.54	14.43	1.91	2.45	2.72	7.62	4.08	0.27	2.45
adipose, donor4	10187-103D7	15.60	5.20	21.67	6.93	5.20	4.33	2.60	1.73	5.20	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	3.31	7.89	4.10	1.58	0.63	1.74	1.74	1.10	1.26	0.79
adrenal gland, adult, pool1	10081-102A9	0.00	0.00	3.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	26.68	8.94	9.34	8.14	3.34	4.00	1.60	3.34	6.27	1.87
alveolar cell carcinoma cell line:SW 1573	10708-109H6	8.22	6.43	10.36	5.00	1.43	3.22	4.64	3.57	3.57	2.86
amniotic membrane cells, donor1	12235-129G3	4.64	7.42	0.70	0.23	2.55	0.46	0.70	0.70	0.00	0.46
amniotic membrane cells, donor2	12236-129G4	4.06	5.75	2.03	0.00	1.01	0.34	0.68	0.34	0.34	0.68
amniotic membrane cells, donor3	12237-129G5	7.37	7.07	1.47	0.00	2.95	0.00	0.29	0.59	0.88	0.59
amygdala - adult, donor10196	10167-103B5	30.83	9.49	9.49	0.00	0.00	0.00	0.00	1.19	0.00	4.74
amygdala, adult, donor10252	10151-102I7	24.74	15.21	9.33	1.22	8.31	2.43	0.61	1.01	0.41	0.81
amygdala, newborn, donor10223	10360-105E9	8.71	1.61	6.13	1.29	2.26	4.84	0.97	1.94	0.97	1.94
anaplastic carcinoma cell line:8305C	10428-106D5	4.58	4.07	6.88	2.55	3.06	2.67	1.91	2.67	2.04	1.78
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	18.97	3.97	5.07	1.99	2.87	3.31	1.32	2.87	3.75	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	7.68	11.02	21.71	4.01	1.67	6.35	12.69	4.34	2.34	5.68
aorta, adult, pool1	10052-101G7	6.47	5.88	2.94	0.20	2.35	0.78	0.00	0.78	0.20	0.00
appendix, adult	10189-103D9	21.35	15.14	24.45	13.58	7.76	6.21	1.55	3.49	3.88	4.27
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	21.67	12.38	20.98	2.75	4.13	6.53	3.10	5.85	5.16	3.78
artery, adult	10190-103E1	8.15	6.79	8.15	1.36	2.72	0.00	1.36	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	3.91	2.75	0.72	0.43	1.45	0.14	1.74	1.01	0.43	0.43
b cell line:RPMI1788	10427-106D4	9.96	10.86	10.56	3.57	1.78	2.23	2.23	1.93	5.65	1.19
basal cell carcinoma cell line:TE 354.T	10702-109G9	2.50	0.28	0.55	0.00	0.00	0.00	0.00	0.28	0.00	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	5.95	6.05	2.58	1.79	1.59	2.98	1.39	3.77	2.38	1.79
bile duct carcinoma cell line:TFK-1	10496-107C1	6.70	7.20	2.51	0.84	0.67	1.67	0.67	0.84	0.33	1.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	8.39	3.91	4.47	1.12	2.24	1.68	1.12	2.80	2.80	0.00
bladder, adult, pool1	10011-101C2	8.80	5.98	4.02	1.52	1.96	0.87	1.20	1.09	0.22	0.22
blood, adult, pool1	10053-101G8	22.15	24.36	8.86	2.21	4.43	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	3.43	2.57	0.00	0.00	0.00	0.86	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	4.72	7.42	1.35	0.67	0.67	2.02	0.67	0.67	0.00	1.35
brain, adult, donor1	10084-102B3	13.33	8.20	4.10	0.00	2.05	0.00	0.00	3.08	0.00	1.03
brain, adult, pool1	10012-101C3	13.81	8.13	4.79	0.67	2.23	1.56	0.67	1.67	0.33	0.56
brain, fetal, pool1	10085-102B4	8.01	2.67	24.04	0.00	0.00	2.67	5.34	0.00	2.67	2.67
breast carcinoma cell line:MCF7	10482-107A5	10.57	11.23	17.51	2.97	2.97	7.60	6.94	3.96	5.62	5.29
breast carcinoma cell line:MDA-MB-453	10419-106C5	8.49	8.24	5.74	0.75	2.37	1.62	1.50	1.62	1.12	1.00
breast, adult, donor1	10080-102A8	6.94	3.16	0.00	0.00	1.89	0.00	0.00	0.00	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	5.46	3.68	3.56	2.54	1.52	1.91	1.52	0.76	1.14	0.76
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	8.66	7.42	8.66	3.40	2.16	2.47	8.97	3.71	2.47	2.78
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	14.96	6.22	7.14	0.69	1.38	3.45	2.53	2.07	2.30	1.15
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	14.28	8.72	6.78	0.48	1.69	2.18	2.42	2.18	0.48	1.94
carcinoid cell line:NCI-H1770	10703-109H1	5.17	8.93	9.87	1.88	1.41	2.82	1.41	2.35	0.47	2.35
carcinoid cell line:NCI-H727	10735-110B6	31.94	11.81	17.39	9.30	12.47	10.06	8.09	6.89	5.47	4.48
carcinoid cell line:SK-PN-DW	10719-109I8	2.54	1.58	10.46	1.27	1.27	1.90	3.17	4.12	1.27	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	11.18	3.99	10.11	1.60	3.46	6.12	13.04	6.12	1.06	4.79
caudate nucleus - adult, donor10196	10177-103C6	14.97	12.66	6.91	0.00	3.45	1.15	1.15	2.30	1.15	2.30
caudate nucleus, adult, donor10252	10164-103B2	15.23	19.24	12.55	0.33	5.35	1.67	0.50	1.67	0.50	0.17
caudate nucleus, adult, donor10258	10379-105H1	3.82	6.88	3.82	0.00	0.76	0.76	0.00	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	10.99	4.39	10.25	0.37	2.20	1.83	0.73	2.56	1.10	0.37
cerebellum - adult, donor10196	10173-103C2	20.39	20.39	17.48	0.00	5.83	2.91	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	37.36	39.71	27.97	0.64	13.45	6.41	2.14	4.48	0.85	0.64
cerebellum, adult, pool1	10083-102B2	6.90	3.79	5.17	1.03	1.03	2.41	0.00	0.69	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	19.93	11.62	37.36	0.83	3.32	5.81	6.64	8.30	3.32	2.49
cerebral meninges, adult	10188-103D8	11.09	2.77	5.80	0.76	2.27	2.02	1.01	0.00	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	5.12	2.19	4.39	0.73	0.73	0.73	0.00	0.00	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	12.80	5.90	5.61	3.16	2.88	4.89	7.48	3.02	3.31	1.58
cervical cancer cell line:ME-180	10553-107I4	8.45	6.79	7.46	0.66	2.82	4.47	3.31	3.81	1.49	4.47
cervix, adult, pool1	10013-101C4	9.55	10.18	4.72	0.63	2.62	2.10	0.94	1.68	0.94	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	7.25	4.32	2.79	0.42	3.34	2.51	1.11	2.23	0.14	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	2.61	2.61	0.00	0.00	1.31	1.31	0.00	1.31	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	32.81	55.05	33.68	3.98	11.18	8.82	7.46	12.43	3.98	3.23
choriocarcinoma cell line:SCH	10785-110H2	3.33	8.26	4.44	0.00	3.82	1.11	0.74	1.23	0.49	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	4.03	20.16	4.03	0.47	2.61	3.08	3.08	2.61	0.71	1.90
chorionic membrane cells, donor1	12238-129G6	3.70	5.98	0.85	0.00	3.70	0.00	0.57	0.28	0.00	0.85
chorionic membrane cells, donor2	12239-129G7	6.76	8.05	2.98	0.00	3.48	0.60	0.99	1.29	0.20	0.89
chorionic membrane cells, donor3	12240-129G8	6.59	9.89	1.10	0.55	3.30	0.55	1.65	1.10	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	5.05	4.04	9.09	6.06	1.01	3.03	0.00	5.05	1.01	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	10.37	4.42	5.76	5.57	1.15	1.34	1.73	1.54	0.96	1.34
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	10.56	3.17	8.24	5.28	0.84	1.27	0.84	1.48	1.69	1.90
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	12.84	3.08	8.73	1.28	3.60	2.57	5.14	2.05	3.08	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	13.55	7.74	10.64	2.66	4.35	2.42	9.19	3.87	3.14	2.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	10.59	9.77	11.81	3.46	3.66	2.65	6.11	2.04	4.68	1.02
chronic myelogenous leukemia cell line:K562	10454-106G4	11.19	1.77	8.83	1.18	3.24	1.77	5.30	0.59	1.18	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	18.50	8.60	29.97	16.42	3.13	6.52	8.34	2.61	4.69	2.09
clear cell carcinoma cell line:JHOC-5	10638-108I8	5.49	2.97	5.03	0.91	1.83	1.60	1.37	1.60	2.97	1.37
clear cell carcinoma cell line:TEN	10636-108I6	4.86	9.89	4.16	0.69	2.08	1.91	1.91	2.60	1.04	1.91
colon carcinoma cell line:CACO-2	10513-107D9	8.24	8.24	6.77	2.01	4.03	2.01	6.96	3.66	1.83	2.20
colon carcinoma cell line:COLO-320	10420-106C6	8.36	23.95	36.49	3.42	6.84	5.32	6.46	5.32	4.18	2.66
colon, adult, donor1	10082-102B1	0.00	11.90	0.00	2.38	1.19	4.76	0.00	2.38	0.00	1.19
colon, adult, pool1	10014-101C5	10.46	15.75	7.17	2.12	1.88	2.59	1.76	2.82	1.41	1.06
colon, fetal, donor1	10070-101I7	9.27	11.12	7.42	2.47	4.33	1.85	1.24	1.85	0.62	2.47
common myeloid progenitor CMP, donor1	12130-128D6	27.50	18.33	36.67	91.67	9.17	18.33	13.75	18.33	9.17	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	22.52	6.37	5.95	0.85	4.25	2.12	1.70	2.12	3.40	2.55
cord blood derived cell line:COBL-a 24h infection	10453-106G3	12.68	5.28	5.43	4.08	2.11	1.81	2.26	1.66	5.13	2.11
cord blood derived cell line:COBL-a untreated	10449-106F8	11.99	6.49	6.77	4.51	2.68	2.26	2.96	2.26	6.49	1.97
corpus callosum, adult, pool1	10042-101F6	17.36	13.82	11.06	1.99	7.19	2.76	1.66	2.43	0.44	0.77
cruciate ligament, donor2	10295-104G7	4.05	4.05	2.43	0.00	1.62	0.00	0.00	0.81	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	5.62	4.82	0.00	0.00	0.80	0.80	0.00	0.80	0.80	0.00
diencephalon, adult	10193-103E4	7.20	5.28	3.84	0.24	2.64	1.20	0.00	1.20	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	2.07	2.07	9.64	10.56	1.38	3.90	1.61	2.76	5.74	2.30
ductal cell carcinoma cell line:KLM-1	10438-106E6	9.74	8.72	5.13	1.54	4.62	2.82	2.31	4.87	1.03	4.36
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	6.26	1.44	2.41	0.72	1.20	1.44	1.44	0.48	0.24	0.24
ductus deferens, adult	10196-103E7	7.97	9.47	2.49	1.00	2.49	0.00	0.50	0.50	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	7.20	10.08	4.32	2.88	1.44	0.00	0.00	2.88	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	12.51	12.51	8.83	3.68	3.68	1.47	2.94	2.21	0.74	1.47
dura mater, adult, donor1	10041-101F5	13.13	8.01	6.77	2.06	0.99	2.97	0.66	1.82	0.33	1.49
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	3.78	2.22	2.22	0.67	4.44	2.89	0.00	2.22	1.11	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	1.86	1.29	3.58	1.00	1.00	1.43	1.00	1.43	1.00	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	16.03	17.88	14.18	2.47	14.18	10.48	3.08	6.17	3.70	6.17
embryonic pancreas cell line:1C3D3	10605-108F2	11.20	9.38	13.32	3.03	4.84	5.15	3.03	8.78	3.63	3.03
embryonic pancreas cell line:1C3IKEI	10606-108F3	17.91	12.97	12.04	2.16	9.57	6.17	2.78	7.41	6.48	4.01
embryonic pancreas cell line:2C6	10603-108E9	14.45	18.39	15.76	9.19	7.88	14.45	2.63	11.82	6.57	6.57
endometrial carcinoma cell line:OMC-2	10497-107C2	15.42	4.36	14.08	3.35	5.70	5.36	6.37	5.03	2.01	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	7.07	11.06	6.52	0.72	1.27	2.72	1.81	2.54	1.09	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	3.38	6.27	3.06	1.13	1.13	1.29	0.80	1.61	0.80	0.48
epidermoid carcinoma cell line:A431	10426-106D3	9.12	5.00	4.78	2.00	3.45	4.67	5.11	4.89	2.11	3.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	8.36	2.42	6.82	1.76	2.75	4.62	1.87	6.27	1.21	3.52
epididymis, adult	10197-103E8	10.47	7.74	4.19	0.63	0.21	1.26	1.47	0.84	0.63	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	2.48	3.73	3.55	1.06	0.53	0.71	2.31	0.18	0.00	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	15.34	3.15	10.62	3.15	2.75	5.90	4.33	3.15	1.57	2.36
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	4.98	8.13	5.24	2.75	2.49	2.23	3.67	1.70	3.93	3.15
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	7.28	10.83	6.79	2.85	4.23	5.41	2.85	4.04	4.53	2.85
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	3.92	8.29	6.16	1.23	2.24	2.69	3.14	2.02	2.91	2.69
esophagus, adult, pool1	10015-101C6	7.22	13.38	3.40	1.59	1.38	1.81	1.06	1.59	0.74	0.96
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	19.41	5.26	12.90	1.13	8.77	2.00	5.01	2.50	1.38	1.13
eye - muscle inferior rectus, donor1	10272-104E2	12.07	0.00	7.24	0.00	0.00	2.41	0.00	7.24	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	4.21	4.21	0.00	0.00	2.10	4.21	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	1.49	2.98	4.46	0.00	4.46	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	4.59	2.29	3.44	0.00	2.29	0.00	0.00	3.44	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	5.83	0.00	2.91	1.46	1.46	1.46	0.00	1.46	0.00	1.46
eye, fetal, donor1	10054-101G9	10.42	7.37	3.81	0.25	2.29	1.02	0.25	0.25	0.51	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	5.26	2.18	3.08	2.31	0.77	1.03	0.38	1.28	0.64	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	10.68	6.65	4.99	2.85	3.80	1.66	4.04	3.32	4.99	1.66
frontal lobe, adult, pool1	10040-101F4	30.49	13.04	7.98	0.94	4.88	1.60	0.38	2.53	0.38	2.35
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	7.21	8.11	11.71	2.40	3.00	5.70	10.51	5.70	1.50	3.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	21.76	4.75	6.67	1.10	3.11	4.85	1.83	4.85	1.19	1.83
gall bladder, adult	10198-103E9	11.59	10.14	5.07	2.41	1.45	1.93	1.69	0.48	0.97	0.24
gamma delta positive T cells, donor1	11937-126A2	19.86	8.05	18.25	19.33	4.29	4.29	0.00	3.76	0.54	3.22
gamma delta positive T cells, donor2	11938-126A3	20.54	9.71	11.95	10.46	6.35	9.71	0.00	8.22	0.37	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	13.10	8.66	10.98	3.59	3.38	4.65	2.96	4.44	1.06	4.01
gastric adenocarcinoma cell line:MKN45	10612-108F9	11.41	10.64	9.67	3.09	6.77	5.03	12.19	6.77	3.67	4.06
gastric cancer cell line:AZ521	10549-107H9	5.08	9.35	5.25	1.48	2.13	2.62	4.43	3.12	2.46	1.48
gastric cancer cell line:GSS	10560-108A2	21.97	21.05	23.80	3.66	3.66	5.49	2.75	10.07	1.83	3.66
gastrointestinal carcinoma cell line:ECC12	10615-108G3	17.82	14.62	13.71	0.69	15.08	4.11	0.69	4.11	1.14	3.43
giant cell carcinoma cell line:LU65	10487-107B1	8.72	1.49	4.93	1.26	2.52	4.47	1.03	5.05	0.34	1.15
giant cell carcinoma cell line:Lu99B	10433-106E1	9.38	7.56	7.84	3.08	1.54	1.54	2.94	1.54	3.78	1.54
glassy cell carcinoma cell line:HOKUG	10688-109F4	6.24	4.24	2.49	0.75	1.25	2.00	2.24	2.24	2.00	2.74
glioblastoma cell line:A172, tech_rep1	10444-106F3	7.07	4.43	4.96	0.53	0.63	1.48	2.01	1.16	0.84	1.58
glioblastoma cell line:A172, tech_rep2	10444-106F3	8.01	5.48	3.65	0.42	0.42	2.81	1.69	2.11	0.28	1.69
glioblastoma cell line:T98G	10485-107A8	8.94	4.30	3.31	0.99	1.77	3.09	2.10	2.65	1.66	1.21
glioma cell line:GI-1	10413-106B8	4.39	5.56	6.44	1.76	3.22	1.76	4.10	2.34	3.22	0.88
globus pallidus - adult, donor10196	10175-103C4	10.20	1.46	3.64	0.00	0.73	0.73	0.00	1.46	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	18.31	24.90	8.79	0.73	8.06	1.95	0.73	2.20	1.22	0.49
globus pallidus, adult, donor10258	10367-105F7	5.48	4.11	1.37	0.00	0.00	0.00	0.00	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	4.26	4.26	2.66	1.07	2.13	3.73	0.53	1.60	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	24.47	9.79	24.47	46.50	4.89	19.58	12.24	14.68	9.79	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	10.93	0.00	0.00	10.93	10.93	0.00	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	10.45	5.23	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	2.56	2.56	2.24	0.32	0.64	0.32	0.00	0.96	0.00	0.64
hIPS +CCl2, biol_rep1	14383-156B9	6.43	4.13	14.23	2.30	3.67	2.75	8.26	1.84	1.84	0.92
hIPS +CCl2, biol_rep2	14384-156C1	11.43	4.12	11.89	2.29	1.83	2.29	7.32	2.29	1.83	0.91
hIPS +CCl2, biol_rep3	14385-156C2	5.80	5.15	12.24	3.22	0.64	4.51	8.37	1.29	1.93	0.64
hIPS, biol_rep1	14380-156B6	2.87	2.87	0.00	0.00	0.00	0.00	1.44	1.44	2.87	1.44
hIPS, biol_rep2	14381-156B7	4.12	9.60	6.17	1.37	0.69	2.06	9.60	0.00	2.06	0.00
hIPS, biol_rep3	14382-156B8	11.03	5.52	3.31	0.00	2.21	0.00	1.10	0.00	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	15.23	8.91	6.90	2.59	0.86	1.15	3.74	2.30	4.31	0.29
heart - mitral valve, adult	10205-103F7	11.06	6.28	2.69	1.20	1.20	1.49	0.60	0.30	0.90	0.90
heart - pulmonic valve, adult	10206-103F8	12.55	7.58	2.61	0.52	1.57	1.31	0.78	0.52	0.78	0.52
heart - tricuspid valve, adult	10207-103F9	19.15	9.99	1.67	2.50	3.33	0.83	0.83	0.00	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	3.88	5.51	0.82	0.41	0.61	0.00	0.41	1.02	0.00	0.20
heart, adult, diseased, donor1	10051-101G6	6.39	1.70	2.13	0.43	0.85	0.43	0.43	0.00	0.43	0.00
heart, adult, pool1	10016-101C7	13.34	7.82	1.15	0.23	2.76	0.23	0.00	0.92	0.00	0.00
heart, fetal, pool1	10046-101G1	18.69	15.40	9.75	2.36	3.70	1.64	2.36	3.29	2.26	1.54
hepatic mesenchymal tumor cell line:LI90	10778-110G4	2.47	2.47	0.00	0.00	0.62	0.00	0.00	0.00	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	7.14	15.46	22.59	4.76	11.89	5.95	39.24	9.51	3.57	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	6.85	12.82	17.13	4.42	2.76	3.20	21.55	2.54	5.08	2.32
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	8.01	11.29	16.99	5.46	2.91	3.88	17.11	4.25	4.85	2.67
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	6.87	16.98	18.90	6.06	4.65	4.45	23.04	3.94	4.85	2.83
hepatoma cell line:Li-7	10484-107A7	15.46	6.23	6.90	0.67	5.12	3.89	1.78	3.23	0.56	1.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	2.01	6.53	5.93	5.93	2.21	1.51	1.71	1.01	5.03	0.70
hippocampus - adult, donor10196	10169-103B7	12.30	0.95	6.62	0.00	6.62	0.00	0.00	0.95	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	21.84	18.98	9.39	1.43	9.59	2.86	0.61	2.45	1.84	0.41
hippocampus, adult, donor10258	10374-105G5	5.48	9.46	1.49	0.00	0.50	0.00	0.00	1.49	1.00	1.00
hippocampus, newborn, donor10223	10363-105F3	5.29	4.58	5.64	0.00	1.06	0.00	0.70	1.06	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	14.65	5.49	39.67	8.54	5.49	9.16	6.10	4.27	6.10	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	11.58	5.69	28.86	6.09	5.69	9.03	6.48	4.71	3.73	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	13.71	7.62	37.07	8.38	6.86	7.87	10.16	4.57	4.57	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	10.15	7.89	31.01	2.26	1.13	7.33	12.41	3.95	2.26	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	18.07	11.36	25.82	3.36	1.55	9.30	12.65	4.91	2.07	1.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	16.70	6.83	26.95	3.04	1.90	3.42	8.35	3.42	1.14	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	11.68	6.13	20.73	2.04	3.50	9.63	5.84	5.26	0.88	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	17.02	6.25	24.77	4.09	5.39	6.68	7.97	5.17	1.08	2.59
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	11.26	6.67	30.03	2.92	3.34	5.00	7.09	5.42	2.92	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	6.16	2.37	9.95	2.37	1.18	6.87	4.26	4.50	0.47	1.66
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	10.29	4.18	15.11	2.57	2.73	7.39	7.39	5.46	1.77	2.73
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	5.39	2.02	11.45	1.35	0.67	9.43	5.39	2.69	2.02	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	14.55	7.82	30.36	7.04	4.38	6.10	6.89	4.38	4.69	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	15.72	4.91	29.48	6.39	4.42	3.93	6.88	3.44	2.46	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	12.22	3.49	25.31	4.36	3.49	5.24	3.49	0.00	0.00	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	24.63	12.98	24.44	3.44	3.25	7.25	12.22	5.54	1.15	1.72
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	17.44	12.65	24.86	1.31	0.44	5.67	9.59	3.05	0.87	2.18
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	16.99	10.00	32.98	4.50	2.50	9.00	7.00	4.00	0.00	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	14.69	4.33	20.35	1.88	3.58	4.14	4.90	3.58	0.38	1.13
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	10.46	4.09	12.28	0.45	3.64	3.18	5.00	2.27	0.91	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	11.90	2.82	15.98	0.63	4.39	3.13	5.01	3.76	0.63	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	6.04	2.94	9.63	1.14	2.12	5.06	3.10	3.59	0.49	2.12
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	8.13	2.32	10.45	0.58	1.74	4.06	3.48	3.77	1.16	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	6.58	4.78	14.05	0.60	2.39	5.08	4.18	2.99	0.60	2.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	11.82	4.25	24.20	7.76	4.06	8.13	9.61	4.43	3.69	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	14.55	4.28	25.68	5.71	3.71	7.42	9.41	4.85	4.28	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	12.66	2.45	31.44	8.98	2.45	11.43	10.21	3.27	4.08	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	9.86	7.39	17.60	2.46	3.52	1.76	5.99	2.46	1.06	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	9.19	4.12	14.57	2.53	2.53	1.90	11.40	3.48	0.95	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	11.80	8.17	20.28	2.12	3.33	5.45	6.36	3.63	2.12	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	6.72	2.59	16.03	1.55	2.59	3.62	5.69	4.65	0.52	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	7.97	3.32	11.95	0.66	1.33	1.99	5.31	0.66	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	3.85	4.87	12.06	0.51	2.82	3.85	3.08	2.31	0.77	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	5.37	4.35	8.44	1.02	1.53	3.07	6.65	3.07	0.26	2.81
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	4.54	3.79	9.09	0.00	0.76	1.51	3.03	1.51	0.76	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	4.03	2.69	7.39	1.01	0.34	2.02	3.70	2.35	1.01	3.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	15.94	6.52	27.29	7.49	6.28	8.94	10.14	4.35	3.86	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	15.60	5.35	32.53	6.68	2.67	7.58	6.68	3.12	3.57	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	14.15	5.37	40.00	5.37	3.90	7.32	6.34	6.34	1.95	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	18.64	11.92	22.62	3.36	3.97	6.72	10.70	3.67	0.92	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	9.76	6.51	22.77	0.00	3.25	3.25	9.76	0.00	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	13.57	3.64	31.77	2.65	1.65	5.96	14.56	4.30	1.99	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	13.68	5.47	19.70	1.64	4.93	4.38	9.85	2.74	2.19	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	6.88	2.90	18.46	1.45	3.98	3.98	5.43	4.70	1.45	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	8.90	4.27	14.23	0.71	1.07	4.27	6.76	2.49	0.71	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	5.97	4.77	7.16	1.19	0.00	4.77	2.39	5.97	3.58	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	8.26	5.01	15.57	1.63	1.90	6.36	5.01	4.88	1.49	1.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	4.58	1.08	10.51	1.89	0.81	3.23	3.23	1.35	1.08	0.81
immature langerhans cells, donor1	11904-125F5	8.96	1.94	1.21	0.73	0.73	0.24	0.24	0.97	0.24	0.73
immature langerhans cells, donor2	11905-125F6	9.51	3.17	3.17	0.00	3.17	0.79	0.00	0.79	0.00	1.58
insula, adult, pool1	10039-101F3	32.27	15.14	10.79	1.04	5.02	3.03	0.66	2.37	0.85	1.04
keratoacanthoma cell line:HKA-1	10791-110H8	2.60	5.85	2.28	0.65	1.95	0.98	0.33	1.63	0.33	1.95
kidney, adult, pool1	10017-101C8	12.42	11.21	4.61	2.20	2.70	1.30	0.90	1.60	1.70	0.50
kidney, fetal, pool1	10045-101F9	15.07	15.70	10.04	1.63	3.47	4.74	3.40	3.11	1.70	0.78
large cell lung carcinoma cell line:IA-LM	10509-107D5	25.85	17.75	14.20	6.53	3.55	4.12	12.64	3.98	6.96	3.55
large cell lung carcinoma cell line:NCI-H460	10839-111E2	4.98	2.35	3.32	0.55	1.11	2.21	2.35	0.97	0.55	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	8.99	4.22	3.85	0.73	3.49	2.02	1.47	4.40	1.28	2.20
left atrium, adult, donor1	10079-102A7	4.90	4.36	1.63	1.09	0.54	1.09	1.09	0.00	0.00	0.54
left ventricle, adult, donor1	10078-102A6	4.55	6.57	0.51	0.51	0.00	0.00	0.00	0.51	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	5.20	1.37	4.65	0.55	0.27	1.37	6.84	1.09	0.00	0.82
leiomyoma cell line:10964C	10569-108B2	2.87	0.72	0.36	0.00	0.00	0.36	0.00	0.72	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	2.17	1.09	0.00	0.00	0.54	0.54	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	1.94	0.49	0.73	0.00	0.24	0.00	0.00	0.00	0.24	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	6.27	4.18	5.23	1.05	1.05	3.14	1.05	4.18	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	20.54	10.27	15.23	7.91	4.13	4.01	5.67	1.65	4.13	1.89
liposarcoma cell line:KMLS-1	10782-110G8	4.84	1.41	0.47	0.31	0.62	0.31	0.31	0.78	0.16	0.16
liposarcoma cell line:SW 872	10726-110A6	1.83	1.46	1.83	0.49	0.49	0.97	0.49	1.10	0.49	0.85
liver, adult, pool1	10018-101C9	4.70	6.00	1.46	0.16	1.62	0.16	0.00	0.65	0.32	0.16
liver, fetal, pool1	10086-102B5	4.70	1.88	1.88	0.00	0.94	0.94	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	16.04	4.81	3.35	1.46	1.75	1.31	0.29	1.02	0.44	0.29
locus coeruleus, adult, donor10252	10165-103B3	15.32	14.03	6.46	0.74	6.27	1.66	0.55	1.66	0.55	0.55
locus coeruleus, adult, donor10258	10375-105G6	5.36	2.54	3.67	0.00	1.13	0.28	0.56	0.00	0.28	0.85
locus coeruleus, newborn, donor10223	10362-105F2	12.20	2.94	4.63	0.42	2.10	2.94	0.42	1.26	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	5.26	5.67	2.77	0.69	3.18	1.52	0.97	0.97	0.97	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	25.51	11.72	14.48	4.14	7.58	11.72	16.55	12.41	3.45	7.58
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	11.73	9.62	7.65	2.24	1.85	4.22	13.71	5.01	2.11	3.03
lung, adult, pool1	10019-101D1	13.47	12.64	4.96	2.01	2.84	1.77	0.71	1.54	0.83	0.24
lung, fetal, donor1	10068-101I5	43.10	22.26	8.56	0.86	3.42	1.14	1.71	2.57	0.86	1.43
lung, right lower lobe, adult, donor1	10075-102A3	12.83	11.91	5.50	1.37	2.29	0.92	0.46	2.29	0.46	1.37
lymph node, adult, donor1	10077-102A5	9.47	12.78	5.21	8.05	3.79	0.95	0.47	2.37	2.37	1.42
lymphangiectasia cell line:DS-1	10727-110A7	3.73	5.26	1.53	1.32	0.66	0.44	0.00	0.22	0.00	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	2.57	3.47	5.74	5.28	1.51	1.66	0.75	2.11	3.47	3.17
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	34.83	5.95	11.04	4.25	2.55	11.04	11.89	6.80	1.70	11.04
mature adipocyte, donor1	12231-129F8	6.22	4.88	1.33	0.44	3.55	0.44	0.00	0.44	0.00	0.89
mature adipocyte, donor2	12232-129F9	6.02	4.15	0.83	0.00	3.32	0.62	0.00	0.62	0.00	0.42
mature adipocyte, donor3	12233-129G1	5.45	4.03	1.19	0.00	2.13	0.24	0.00	0.47	0.00	1.19
mature adipocyte, donor4	12234-129G2	5.26	4.21	0.79	0.26	0.53	0.79	0.26	0.79	0.00	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	16.20	18.11	13.10	3.10	10.72	5.72	5.24	4.77	2.14	2.86
medial frontal gyrus - adult, donor10196	10170-103B8	31.58	10.15	6.77	2.26	1.13	0.00	1.13	0.00	0.00	3.38
medial frontal gyrus, adult, donor10252	10150-102I6	26.30	17.47	11.59	0.55	7.91	1.84	0.74	1.29	0.74	1.47
medial frontal gyrus, adult, donor10258	10368-105F8	9.53	3.49	2.86	0.32	1.59	0.95	0.00	0.95	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	14.07	2.56	7.68	0.85	1.71	2.13	0.85	0.85	0.85	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	30.21	7.43	6.24	0.34	3.21	2.19	0.51	1.86	0.17	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	28.23	20.80	6.79	0.85	9.55	2.12	0.64	2.76	0.85	2.12
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	5.78	1.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	14.35	0.00	0.00	0.00	0.00	0.00	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	15.08	2.15	8.26	0.72	2.87	1.08	0.72	4.67	1.44	2.15
medulla oblongata - adult, donor10196	10174-103C3	7.79	3.89	4.54	0.65	2.60	0.00	0.00	1.95	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	16.41	17.49	9.13	1.86	8.51	3.10	0.62	1.86	1.08	0.93
medulla oblongata, adult, pool1	10038-101F2	15.51	7.59	6.04	1.22	4.00	1.71	0.49	2.29	0.65	0.98
medulla oblongata, newborn, donor10223	10361-105F1	5.55	3.12	2.43	0.69	2.08	0.69	0.00	1.74	1.04	0.35
medulloblastoma cell line:D283 Med	10838-111E1	5.98	8.86	25.91	4.65	2.88	7.53	15.06	3.32	2.66	1.55
medulloblastoma cell line:ONS-76	10759-110E3	10.27	2.69	6.36	6.36	3.67	3.55	6.73	2.08	3.06	2.08
melanoma cell line:COLO 679	10514-107E1	1.87	1.29	1.87	2.87	1.29	2.59	0.86	2.30	0.57	2.16
melanoma cell line:G-361	10465-106H6	1.90	0.27	1.09	1.90	0.81	0.81	2.17	2.71	1.09	2.71
meningioma cell line:HKBMM	10691-109F7	3.98	1.81	1.81	1.81	1.81	2.35	0.90	3.26	0.72	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	6.17	13.22	31.72	8.81	3.52	9.69	9.69	6.17	1.76	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	5.18	4.41	16.33	3.63	4.41	2.85	3.37	2.07	3.63	3.11
mesenchymal precursor cell - adipose, donor1	11747-123G1	0.46	0.92	0.15	0.31	0.15	0.00	0.00	0.61	0.00	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	2.54	0.18	0.36	0.18	0.18	0.55	0.36	0.18	0.00	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	2.07	2.07	0.41	0.00	0.00	0.00	0.00	0.00	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	2.39	1.40	0.56	0.00	0.56	0.14	0.00	0.42	0.28	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	2.31	0.96	0.00	0.19	0.00	0.00	0.58	0.19	0.19	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	0.69	0.69	0.00	0.00	1.39	0.00	0.00	0.00	0.69	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	2.40	2.23	0.17	0.00	0.34	0.00	0.00	0.17	0.00	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	1.73	1.15	0.58	0.00	0.35	0.12	0.00	0.12	0.00	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	2.25	1.06	0.40	0.27	0.13	0.13	0.53	0.13	0.40	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	2.16	1.89	0.27	0.14	0.27	0.14	0.00	0.00	0.27	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	2.70	1.28	0.28	0.00	0.43	0.14	0.71	0.14	0.00	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	5.27	1.98	0.33	0.66	0.33	0.66	0.99	0.00	0.00	1.65
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	2.77	0.55	0.55	0.14	0.42	0.28	0.14	0.00	0.00	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	1.40	0.00	0.70	0.00	0.00	0.35	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	2.25	2.25	0.00	0.00	0.20	0.20	0.00	0.00	0.00	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	3.24	0.72	1.80	0.00	0.00	0.72	0.72	1.08	0.00	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	2.17	1.24	0.93	0.00	0.10	0.52	0.10	0.41	0.10	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	2.96	0.46	0.23	0.00	0.68	0.23	0.00	0.00	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	1.68	0.00	0.00	0.00	0.00	0.00	0.00	0.42	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	1.94	0.45	0.45	0.15	0.15	0.00	0.00	0.15	0.00	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	2.80	1.93	0.53	0.18	0.26	0.35	0.61	0.18	0.35	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	2.21	2.58	0.00	0.00	1.10	0.37	0.37	0.74	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	3.15	1.72	0.57	0.00	0.00	0.57	0.57	0.29	0.57	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	0.84	2.11	0.42	0.42	0.00	1.26	2.11	0.84	0.84	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	0.91	1.37	0.00	0.00	0.91	0.46	0.00	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	0.51	0.26	0.51	0.00	0.00	0.00	0.00	0.26	0.26	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	1.83	0.79	0.26	0.00	0.00	0.26	0.26	0.00	0.00	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	1.85	0.92	0.62	0.00	0.31	0.00	0.62	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	1.18	0.47	0.24	0.00	0.47	0.24	0.00	0.00	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	1.35	2.03	0.34	0.00	0.34	0.00	0.34	0.00	0.34	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	0.39	0.00	0.00	0.00	0.39	0.39	0.39	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	0.93	0.46	0.46	0.00	0.00	0.00	0.00	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	2.02	0.87	0.00	0.00	0.87	0.00	0.00	0.29	0.29	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	1.78	0.67	0.00	0.22	0.00	0.00	0.00	0.67	0.22	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	1.68	0.96	0.24	0.00	0.24	0.00	0.00	0.00	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	2.20	0.73	0.73	0.00	0.00	0.00	0.00	0.00	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	1.34	0.67	0.00	0.00	0.00	0.00	0.00	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	1.23	0.41	0.00	0.00	0.82	0.00	0.41	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	1.29	1.72	0.00	0.00	0.00	0.00	0.00	0.43	0.43	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	1.30	0.65	0.00	0.00	0.32	0.32	0.00	0.00	0.00	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	0.53	1.07	0.00	0.00	0.53	0.00	1.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	0.00	0.00	0.00	0.00	0.82	0.00	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	1.17	0.39	0.39	0.00	0.00	0.39	0.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	0.00	1.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	1.78	2.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	2.44	3.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	1.27	0.00	0.63	0.00	0.00	0.00	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	2.07	0.34	1.03	0.34	0.34	0.34	0.34	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	2.15	0.00	2.15	2.15	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	0.00	3.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	1.63	1.22	0.81	0.00	0.41	0.00	0.00	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	0.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	0.59	1.18	0.59	0.00	0.00	0.00	1.18	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	1.25	1.25	0.31	0.00	0.00	0.31	0.00	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	1.34	2.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	2.37	1.18	1.18	0.00	0.00	0.00	0.00	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	0.69	1.38	0.00	0.69	0.00	0.00	0.69	1.38	0.00	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	0.00	0.49	0.00	0.49	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	0.00	1.12	0.00	0.00	1.12	0.00	1.12	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	0.64	1.91	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	0.81	0.00	0.00	0.00	0.00	0.00	0.40	0.00	0.40	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1.27	1.27	1.27	0.00	1.27	0.00	0.00	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	1.21	3.64	0.00	0.00	1.21	0.00	0.00	0.61	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	4.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	0.82	3.29	0.00	0.00	1.65	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	1.19	0.99	0.60	0.00	0.20	0.00	0.00	0.20	0.40	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	0.97	1.30	0.32	0.00	0.32	0.32	0.00	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	0.00	1.02	1.02	0.00	0.00	0.00	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	7.74	6.96	3.09	0.00	0.77	0.77	2.32	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	6.61	21.50	6.38	0.47	2.83	3.78	1.42	2.60	0.47	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	7.65	1.85	6.26	1.16	2.78	3.94	7.88	5.56	1.16	3.24
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	4.27	4.27	0.00	0.00	0.00	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	5.96	2.36	3.80	0.82	1.85	3.70	1.13	1.75	1.34	1.03
mesothelioma cell line:Mero-25	10850-111F4	7.72	1.82	3.40	1.82	1.59	0.91	3.86	1.36	1.59	2.04
mesothelioma cell line:Mero-41	10851-111F5	4.16	2.44	2.69	0.73	0.24	1.47	1.71	2.44	0.73	1.22
mesothelioma cell line:Mero-48a	10852-111F6	2.88	2.66	2.21	0.66	0.66	0.89	0.66	0.89	0.89	1.33
mesothelioma cell line:Mero-82	10853-111F7	11.04	3.94	4.99	1.05	2.37	1.05	2.89	2.37	1.31	3.15
mesothelioma cell line:Mero-83	10854-111F8	4.09	1.87	1.87	1.36	0.51	1.19	0.85	1.36	1.87	0.17
mesothelioma cell line:Mero-84	10855-111F9	2.78	10.36	0.00	1.01	0.51	0.00	2.02	0.51	0.51	0.51
mesothelioma cell line:Mero-95	10856-111G1	4.76	6.63	3.73	1.24	0.62	0.41	1.45	1.04	1.86	2.28
mesothelioma cell line:NCI-H2052	10847-111F1	1.99	0.99	0.66	0.17	0.33	0.66	0.17	0.99	0.33	0.17
mesothelioma cell line:NCI-H226	10846-111E9	2.71	0.90	0.90	0.00	0.18	0.36	0.18	0.18	0.18	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	3.93	4.10	1.88	0.51	0.68	1.37	0.51	1.54	1.02	0.17
mesothelioma cell line:NCI-H28	10845-111E8	4.83	7.63	10.94	2.29	1.53	3.05	8.65	2.29	3.05	1.78
mesothelioma cell line:No36	10857-111G2	2.61	2.28	1.30	0.98	0.00	0.33	0.65	0.65	0.00	0.65
mesothelioma cell line:ONE58	10858-111G3	3.52	2.71	0.54	0.27	0.27	1.35	0.27	1.90	0.54	1.08
migratory langerhans cells, donor1	11901-125F2	2.69	7.10	0.58	0.38	0.38	0.38	0.38	0.38	0.19	1.34
migratory langerhans cells, donor2	11902-125F3	2.81	6.72	0.61	0.12	0.61	0.37	0.24	0.24	0.12	0.37
migratory langerhans cells, donor3	11903-125F4	5.20	7.00	1.62	0.18	0.54	0.18	0.00	0.36	0.00	0.90
mixed mullerian tumor cell line:HTMMT	10689-109F5	8.81	3.59	3.92	0.00	3.92	1.96	1.31	2.94	0.65	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	1.48	2.33	3.60	1.06	1.06	0.64	1.91	1.48	0.42	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	13.82	1.84	2.53	1.38	3.46	4.61	3.23	5.30	0.00	2.76
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	8.56	4.00	2.09	2.28	1.33	0.38	0.95	0.00	1.71	0.95
myelodysplastic syndrome cell line:SKM-1	10772-110F7	6.28	6.28	18.11	13.86	4.25	5.54	3.70	3.88	5.54	1.85
myeloma cell line:PCM6	10474-106I6	11.07	8.50	2.77	2.17	2.97	1.19	2.97	1.58	2.97	1.19
myxofibrosarcoma cell line:MFH-ino	10600-108E6	2.54	2.03	1.01	0.51	0.00	1.01	1.52	1.52	0.00	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	7.06	1.77	0.78	0.39	0.98	0.59	0.20	0.98	0.00	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	4.46	2.12	1.23	0.00	1.89	0.89	0.45	0.78	0.00	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	4.12	1.91	0.88	0.29	1.62	1.10	0.15	1.03	0.15	0.29
nasal epithelial cells, donor2	12227-129F4	3.31	4.42	1.66	0.55	0.55	0.55	1.10	1.66	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	23.70	17.02	39.34	10.58	13.11	13.80	21.63	14.03	3.68	6.67
neuroblastoma cell line:NB-1	10539-107G8	17.40	5.99	15.34	3.74	1.87	5.05	11.23	1.87	4.68	1.50
neuroblastoma cell line:NBsusSR	10607-108F4	4.22	8.86	14.34	1.69	5.06	5.27	1.48	2.95	1.48	1.27
neuroblastoma cell line:NH-12	10555-107I6	8.01	11.18	25.53	8.76	4.47	10.25	15.65	14.54	3.17	5.59
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	4.98	4.27	16.13	1.42	2.85	8.54	3.32	3.80	1.19	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	4.59	5.38	8.87	2.85	3.96	2.38	2.53	2.22	1.43	1.27
neuroectodermal tumor cell line:TASK1	10774-110F9	2.21	1.61	5.84	0.81	0.81	1.21	0.81	1.81	1.61	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	3.18	10.17	37.51	2.54	1.27	6.36	3.18	6.36	1.27	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	2.93	0.80	0.00	0.00	0.53	0.53	0.00	0.27	0.00	0.00
neutrophil PMN, donor1	12133-128D9	14.87	59.50	14.87	14.87	29.75	29.75	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	28.41	9.47	0.00	0.00	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	8.63	4.57	6.09	9.64	6.43	0.17	1.52	1.52	2.71	1.35
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	10.41	7.20	8.81	0.80	1.60	4.80	3.20	0.80	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	1.60	2.24	0.64	0.00	0.64	0.00	0.64	0.32	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	4.47	1.58	0.00	0.00	0.79	0.53	0.26	0.26	0.26	0.26
nucleus accumbens, adult, pool1	10037-101F1	26.62	14.90	9.00	0.56	4.22	1.31	0.94	1.97	0.66	0.66
occipital cortex - adult, donor10196	10172-103C1	18.54	12.36	6.18	0.00	2.06	2.06	0.00	2.06	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	23.62	17.98	10.20	1.88	6.44	4.83	0.81	1.88	1.61	0.27
occipital cortex, newborn, donor10223	10355-105E4	16.01	4.37	6.91	0.36	1.09	3.28	1.09	2.18	0.73	1.82
occipital lobe, adult, donor1	10076-102A4	19.16	6.56	4.99	0.52	2.62	0.79	1.05	2.62	0.00	1.05
occipital lobe, fetal, donor1	10073-102A1	17.16	6.44	39.91	1.29	3.43	9.87	6.87	4.72	3.00	1.72
occipital pole, adult, pool1	10036-101E9	23.02	12.77	7.73	1.02	4.10	1.26	0.63	1.89	0.55	1.02
olfactory region, adult	10195-103E6	14.14	10.89	5.16	0.76	2.29	2.10	1.15	0.96	0.38	0.19
optic nerve, donor1	10277-104E7	2.00	2.00	2.00	0.00	2.00	2.00	2.00	4.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	4.33	11.50	6.26	1.37	5.24	2.62	2.28	2.16	1.59	2.96
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	9.89	3.85	4.53	1.65	1.65	2.20	3.98	4.26	1.37	1.51
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	10.33	5.42	5.42	2.03	2.54	2.71	3.56	2.03	0.85	3.05
oral squamous cell carcinoma cell line:SAS	10544-107H4	6.24	6.47	1.73	1.39	1.04	1.39	3.70	2.66	1.73	3.70
osteoclastoma cell line:Hs 706.T	10704-109H2	2.94	1.18	1.18	0.29	0.59	0.59	0.29	0.88	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	21.49	6.54	13.08	12.15	10.28	24.29	14.02	27.10	18.69	5.61
osteosarcoma cell line:HS-Os-1	10558-107I9	6.79	3.82	5.30	1.70	1.70	1.70	3.39	5.30	0.64	1.48
ovary, adult, pool1	10020-101D2	5.85	6.11	3.32	0.70	1.48	0.87	1.22	0.79	0.96	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	2.20	1.10	1.65	0.18	0.37	0.55	0.37	0.55	0.37	0.00
pancreas, adult, donor1	10049-101G4	7.53	14.11	0.00	1.88	2.82	1.88	0.00	1.88	1.88	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	8.11	10.34	11.18	0.84	4.19	3.07	3.63	5.59	2.24	3.07
papillary adenocarcinoma cell line:8505C	10437-106E5	4.94	2.90	4.26	2.56	1.87	2.56	2.73	2.38	1.70	1.87
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	11.26	6.62	6.29	2.98	1.99	4.47	1.82	5.46	2.65	2.81
paracentral gyrus, adult, pool1	10035-101E8	25.08	9.70	8.60	0.92	3.75	1.56	0.92	1.83	0.37	1.10
parietal cortex, adult, donor10258	10373-105G4	9.54	5.87	2.94	0.73	0.00	0.00	0.73	1.47	1.47	2.20
parietal lobe - adult, donor10196	10171-103B9	15.99	6.58	3.76	0.00	2.82	2.82	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	29.93	13.68	8.84	2.28	7.70	2.28	0.57	2.85	2.28	0.29
parietal lobe, adult, pool1	10034-101E7	27.67	13.66	9.96	1.06	4.58	2.64	0.79	2.11	0.53	1.76
parietal lobe, fetal, donor1	10072-101I9	14.55	5.82	38.79	3.88	0.97	7.76	1.94	2.91	3.88	0.97
parietal lobe, newborn, donor10223	10356-105E5	13.09	4.86	10.47	0.75	0.37	1.87	0.75	2.99	0.75	1.87
parotid gland, adult	10199-103F1	3.08	14.18	1.85	0.00	2.47	1.23	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	11.82	7.52	1.61	1.07	1.07	0.54	1.07	0.54	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	15.25	4.28	7.62	0.37	12.46	3.16	1.86	5.76	0.74	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	8.60	4.37	2.62	0.73	2.62	1.02	1.75	1.46	0.44	1.31
pineal gland - adult, donor10196	10179-103C8	28.38	7.10	7.74	0.00	5.16	0.00	0.65	1.29	0.65	1.29
pineal gland, adult, donor10252	10160-103A7	33.16	17.77	7.11	0.00	11.84	1.18	0.59	1.18	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	16.30	7.52	4.39	0.00	1.25	0.00	0.63	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	14.17	10.12	4.05	0.00	1.01	2.02	0.00	0.00	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	20.33	24.50	5.73	0.00	9.90	2.08	0.00	1.04	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	3.40	6.81	0.85	0.00	0.85	0.00	0.00	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	15.91	17.85	5.05	0.86	6.34	2.04	0.75	2.47	0.86	2.04
plasma cell leukemia cell line:ARH-77	10840-111E3	5.56	3.84	7.95	5.96	3.84	2.25	1.72	0.93	2.65	2.65
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	5.14	5.29	2.02	0.16	1.87	2.49	0.31	1.87	0.47	0.00
pons, adult, pool1	10033-101E6	15.49	8.35	5.77	0.43	3.53	0.77	0.52	1.55	0.26	0.77
postcentral gyrus, adult, pool1	10032-101E5	24.67	11.86	7.67	0.70	2.96	1.74	0.70	1.13	0.26	0.96
promyelocytes/myelocytes PMC, donor1	12132-128D8	18.82	6.27	10.46	48.10	0.00	2.09	8.37	6.27	2.09	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	5.51	5.51	0.00	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	3.50	7.28	3.93	0.87	1.31	2.04	1.02	2.18	1.02	1.17
prostate cancer cell line:PC-3	10439-106E7	4.17	7.62	6.17	2.18	1.82	1.63	5.08	1.45	2.54	0.36
prostate, adult, pool1	10022-101D4	8.34	11.43	4.72	1.00	3.72	1.36	0.54	1.54	0.91	0.82
putamen, adult, donor10196	10176-103C5	17.47	16.29	11.09	0.00	6.61	1.89	0.94	0.00	0.47	0.00
putamen, adult, donor10252	10152-102I8	5.88	9.80	3.92	0.00	1.96	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	4.37	12.02	8.74	0.00	0.00	0.00	3.28	1.09	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	6.77	13.05	5.32	0.24	1.69	0.00	0.24	0.48	0.48	0.72
putamen, newborn, donor10223	10365-105F5	16.49	2.25	9.75	0.75	0.75	1.50	0.75	0.00	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	20.07	8.73	9.31	2.33	9.60	4.07	7.56	4.65	0.58	2.91
rectum, fetal, donor1	10067-101I4	9.74	0.00	8.35	1.39	0.00	6.95	2.78	0.00	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	4.03	2.54	5.09	1.48	1.27	2.33	0.21	2.54	1.06	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	6.63	6.63	11.60	4.56	3.31	3.73	2.49	7.04	1.66	0.83
retina, adult, pool1	10030-101E3	12.42	12.13	5.86	1.29	4.08	1.89	0.40	1.59	0.50	1.19
retinoblastoma cell line:Y79	10475-106I7	7.79	7.01	24.42	1.56	2.34	5.98	5.46	4.94	2.86	2.08
rhabdomyosarcoma cell line:KYM-1	10787-110H4	1.72	3.44	3.69	1.23	0.37	0.74	1.48	1.48	0.74	0.61
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	8.44	15.75	26.15	6.75	13.22	16.31	23.06	14.62	6.19	5.62
sacrococcigeal teratoma cell line:HTST	10695-109G2	6.06	2.27	3.79	0.76	3.79	2.27	0.76	2.27	0.76	1.52
salivary acinar cells, donor1	11771-123I7	5.18	3.88	2.91	1.62	1.13	1.13	2.91	0.32	1.13	2.27
salivary acinar cells, donor2	11772-123I8	5.09	5.92	3.30	1.38	1.10	1.51	3.99	0.96	1.51	1.38
salivary acinar cells, donor3	11773-123I9	13.90	12.58	2.65	3.31	5.30	0.66	3.31	0.66	3.97	3.97
salivary gland, adult, pool1	10093-102C3	9.15	13.15	2.29	2.86	2.29	1.14	0.57	1.72	0.00	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	8.60	3.37	1.69	0.51	1.10	1.35	0.17	1.43	0.42	1.69
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	7.88	3.64	1.29	0.24	1.41	1.06	0.12	1.29	0.47	0.82
seminal vesicle, adult	10201-103F3	6.88	13.23	3.70	1.59	2.12	2.12	0.53	1.59	1.59	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	5.10	4.62	3.16	0.73	0.73	1.46	0.97	1.21	1.21	2.19
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	2.26	2.77	1.26	0.25	0.50	0.75	0.75	0.50	0.00	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	2.01	1.00	1.00	0.00	0.00	1.00	1.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	5.37	12.63	9.94	3.36	2.82	2.96	4.16	3.63	2.42	1.61
signet ring carcinoma cell line:Kato III	10436-106E4	9.95	3.54	3.65	2.32	2.32	4.75	2.98	3.54	1.11	2.21
signet ring carcinoma cell line:NUGC-4	10483-107A6	8.64	9.03	4.90	3.23	1.16	4.00	4.26	3.87	3.10	1.16
skeletal muscle - soleus muscle, donor1	10282-104F3	0.71	0.00	2.84	0.00	2.84	0.00	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	5.04	4.92	2.88	0.72	2.04	1.44	0.72	4.08	0.36	0.96
skeletal muscle, fetal, donor1	10066-101I3	4.02	1.01	4.02	0.00	1.01	1.01	2.01	5.03	0.00	1.01
skin, adult, donor1	10074-102A2	6.79	0.00	6.79	0.00	0.00	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	6.31	11.99	8.21	1.89	1.26	2.52	1.26	0.63	1.26	3.16
small cell cervical cancer cell line:HCSC-1	10800-110I8	2.33	5.67	4.34	0.67	1.00	0.33	0.67	1.00	0.00	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	16.08	4.73	17.97	3.47	2.84	4.41	14.50	5.36	5.04	5.67
small cell lung carcinoma cell line:DMS 144	10841-111E4	3.28	6.75	5.98	0.19	1.16	0.77	1.35	0.58	0.58	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	23.74	8.74	7.42	8.57	4.78	8.08	12.86	6.92	3.13	4.45
small cell lung carcinoma cell line:NCI-H82	10842-111E5	8.53	23.48	42.30	2.41	8.04	4.50	1.61	2.25	0.80	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	11.99	6.10	7.41	2.83	1.31	3.27	8.93	3.92	1.74	3.92
small intestine, adult, pool1	10024-101D6	14.57	16.60	4.90	3.46	2.87	1.07	0.96	1.19	0.60	1.55
small intestine, fetal, donor1	10064-101I1	7.37	5.16	8.11	1.23	1.23	2.21	1.47	1.47	0.74	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	15.39	3.08	3.59	1.54	5.64	3.08	0.51	4.62	1.54	1.03
smooth muscle, adult, pool1	10048-101G3	8.01	4.65	2.84	0.52	1.29	0.26	0.00	2.07	0.26	0.26
somatostatinoma cell line:QGP-1	10781-110G7	48.78	16.08	13.13	1.88	6.43	3.75	2.41	2.41	1.61	1.88
spinal cord - adult, donor10196	10181-103D1	12.16	5.74	3.90	0.69	2.52	1.38	0.23	0.92	0.46	0.23
spinal cord, adult, donor10252	10159-103A6	20.50	21.29	5.13	2.37	4.73	2.37	0.00	1.58	1.18	0.00
spinal cord, adult, donor10258	10369-105F9	2.77	3.46	1.38	0.69	0.69	0.00	0.69	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	10.37	7.32	3.66	0.61	4.27	4.27	0.00	1.83	0.61	1.22
spinal cord, newborn, donor10223	10359-105E8	6.89	2.30	4.13	0.00	0.92	2.30	0.92	0.46	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	2.54	1.34	0.75	0.00	0.30	0.15	0.00	0.00	0.00	0.30
spleen, adult, pool1	10025-101D7	20.48	23.02	14.54	11.89	4.52	1.87	0.77	1.87	3.74	1.43
spleen, fetal, pool1	10044-101F8	21.93	19.78	14.78	9.93	5.80	3.65	1.83	2.46	3.42	2.46
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	2.48	8.59	8.18	6.11	0.52	1.97	1.14	0.83	5.18	1.04
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	22.22	11.96	6.65	1.52	4.56	1.33	1.90	3.23	1.14	2.66
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	3.84	9.78	1.40	0.00	3.15	0.70	1.40	0.70	0.35	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	14.07	2.74	4.69	1.56	3.91	3.52	0.78	5.47	2.35	4.69
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	11.82	4.50	3.49	0.45	3.38	1.46	1.46	1.69	1.46	1.24
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	17.79	11.86	6.78	3.81	2.54	5.51	2.12	2.54	2.12	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	8.88	4.23	4.65	0.42	0.00	2.96	1.27	2.54	2.54	1.69
stomach, fetal, donor1	10062-101H8	7.48	2.14	3.20	4.27	3.20	5.34	0.00	2.14	0.00	1.07
submaxillary gland, adult	10202-103F4	7.98	11.39	2.85	3.99	1.14	0.00	0.00	0.00	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	13.50	16.20	8.72	1.45	7.69	3.12	0.21	1.87	0.21	0.62
substantia nigra, adult, donor10258	10371-105G2	5.17	5.69	2.07	0.52	1.03	1.03	0.00	2.59	1.03	0.00
substantia nigra, newborn, donor10223	10358-105E7	5.65	2.12	2.12	1.41	2.12	1.41	0.00	2.12	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	1.83	4.13	7.11	1.60	1.83	2.06	2.06	1.15	0.69	0.69
temporal lobe, adult, pool1	10031-101E4	25.18	12.55	9.49	1.10	3.56	2.54	1.02	1.86	0.59	1.19
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	13.53	8.55	42.74	2.85	3.56	9.26	4.27	7.12	3.56	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	14.07	7.91	29.01	1.76	3.96	9.23	7.47	7.47	1.76	2.20
tenocyte, donor1	11763-123H8	6.63	2.44	0.35	0.00	0.70	0.70	0.70	0.35	0.00	0.00
tenocyte, donor2	11765-123I1	1.91	3.82	1.53	0.00	0.00	1.14	0.00	0.38	0.00	0.38
tenocyte, donor3	11768-123I4	1.85	1.48	0.00	0.00	0.00	0.37	0.00	0.37	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	8.33	6.80	14.62	3.74	3.40	7.31	10.20	4.59	2.21	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	4.62	10.17	13.41	3.08	3.85	5.70	6.63	6.94	1.85	2.00
teratocarcinoma cell line:PA-1	10807-111A6	9.14	4.96	8.52	2.32	4.80	2.94	3.87	1.24	0.93	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	20.57	7.36	32.37	3.81	14.35	12.82	17.90	7.49	2.54	1.78
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	31.01	13.61	49.16	3.78	20.80	15.13	15.88	9.83	2.27	2.65
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	29.12	14.40	29.56	2.51	22.79	13.41	14.94	7.96	1.31	2.29
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	8.14	4.89	33.22	8.47	17.59	17.91	40.71	28.66	3.26	1.95
testis, adult, pool1	10026-101D8	14.07	7.84	6.23	2.04	3.87	2.47	6.23	3.65	3.11	2.15
testis, adult, pool2	10096-102C6	19.85	9.47	3.61	4.06	5.41	4.06	13.08	3.16	6.32	1.35
thalamus - adult, donor10196	10168-103B6	13.25	6.62	3.31	0.00	4.42	2.21	0.00	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	16.57	21.72	10.78	1.41	9.22	2.03	0.00	1.56	0.47	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	3.08	7.70	0.00	0.00	0.00	1.54	1.54	3.08	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	5.27	3.13	2.96	0.16	0.66	0.49	0.33	1.32	0.33	0.16
thalamus, newborn, donor10223	10366-105F6	6.90	1.15	3.45	0.00	1.15	1.15	1.15	1.15	0.00	0.58
throat, adult	10209-103G2	8.49	5.74	7.74	2.25	2.25	1.25	1.50	2.00	0.50	1.50
throat, fetal, donor1	10061-101H7	9.14	5.48	3.96	2.13	2.74	1.83	1.22	1.52	0.61	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	0.40	9.74	17.69	2.98	0.79	4.77	4.37	3.38	1.99	0.60
thymus, adult, pool1	10027-101D9	11.43	22.67	62.63	23.36	7.95	7.75	1.79	3.98	5.67	1.89
thymus, fetal, pool1	10043-101F7	21.30	35.12	54.55	23.48	15.38	7.79	2.39	6.65	4.78	1.66
thyroid carcinoma cell line:KHM-5M	10776-110G2	5.98	1.46	2.66	0.66	2.13	2.93	0.40	1.99	0.93	1.06
thyroid carcinoma cell line:TCO-1	10783-110G9	5.59	2.51	3.77	1.26	3.07	3.63	3.91	2.24	1.68	2.37
thyroid, adult, pool1	10028-101E1	10.64	13.62	3.45	0.56	2.99	1.40	0.84	0.56	0.65	0.19
thyroid, fetal, donor1	10060-101H6	11.07	7.91	2.64	0.00	2.37	1.58	0.53	0.53	0.26	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	12.32	3.08	12.32	3.08	3.08	6.16	3.08	3.08	3.08	0.00
tongue, adult	10203-103F5	5.58	3.95	3.02	1.63	2.09	1.40	0.70	0.93	0.00	1.16
tongue, fetal, donor1	10059-101H5	7.49	3.15	1.97	1.58	1.58	0.00	0.00	0.00	1.18	0.79
tonsil, adult, pool1	10047-101G2	19.33	19.83	17.23	13.52	7.11	4.61	1.20	5.11	3.11	4.01
trachea, adult, pool1	10029-101E2	9.57	11.78	3.76	1.80	1.88	1.31	1.31	1.31	0.90	1.23
trachea, fetal, donor1	10058-101H4	6.54	4.62	4.23	0.38	1.92	0.77	0.38	0.00	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	1.06	0.35	0.00	0.00	0.00	0.00	0.00	0.00	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	11.45	5.78	13.37	4.46	3.85	5.47	9.32	6.59	3.75	3.65
transitional-cell carcinoma cell line:JMSU1	10492-107B6	8.30	7.99	10.97	1.88	2.66	4.54	3.29	4.23	1.72	1.25
tridermal teratoma cell line:HGRT	10694-109G1	3.81	0.00	1.90	3.81	0.00	3.81	0.00	3.81	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	10.67	4.32	3.13	0.85	2.71	1.19	1.78	1.35	1.27	1.27
umbilical cord, fetal, donor1	10057-101H3	4.17	6.26	0.00	0.00	0.00	2.09	2.09	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	10.58	8.36	4.78	0.51	1.54	0.51	1.19	2.05	0.51	0.51
uterus, fetal, donor1	10055-101H1	4.10	4.61	4.10	1.54	0.51	1.54	1.02	0.51	1.02	0.51
vagina, adult	10204-103F6	8.40	11.63	1.94	1.29	5.82	1.94	0.65	0.65	0.00	0.00
vein, adult	10191-103E2	12.71	10.52	16.88	11.84	4.82	3.29	1.10	3.07	3.51	1.32
xeroderma pigentosum b cell line:XPL 17	10563-108A5	4.54	5.87	4.27	2.67	0.27	1.07	1.60	0.53	0.53	0.53